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ABSTRACT 
 
Biodegradable bone fixation implants have been used successfully in certain orthopaedic applications for 
more than two decades. The main advantage of biodegradable implants is avoidance of secondary removal of 
hardware, often required after treatment with conventional metallic devices. However, biodegradable 
implants are usually not suitable for high-load bearing applications unless used in conjunction with traditional 
rigid fixation or appropriate additional external immobilization. In order to achieve sufficient fixation 
stability, biodegradable fixation implants are typically made thicker and wider than the corresponding metal 
implants. The adequacy of novel materials and bone fixation implants needs to be demonstrated prior to their 
approval by the authorities and clinical adoption by surgeons. This is typically done by conducting in vitro 
testing, preclinical in vivo testing and clinical testing. 
 
In this thesis, product- and indication-specific static and cyclic biomechanical test methods were developed to 
investigate fixation properties of biodegradable bone fixation plate-screw constructs. In all biomechanical 
tests artificial carrier materials were used as a substitute for human bone fragments. The fixation properties, 
as well as degradation behavior and clinical suitability of biodegradable bone fixations implants made from a 
co-polymer of L-lactic acid, D-lactic acid and trimethylene carbonate (PLDLA/TMC) were evaluated under 
hydrolytic in vitro conditions. A novel fixation concept with cut-off screw heads providing a low-profile 
fixation was compared to conventional fixation in static biomechanical tests over a 26-week period. The 
fixation properties provided by a biodegradable ankle plate for lateral malleolar fracture, a typical fracture of 
the ankle, were investigated in a cyclic biomechanical test with a physiological loading model and an 
evaluation period corresponding to the time needed for fracture healing. In addition to the biomechanical 
tests, a static mechanical shear test and, inherent viscosity and mass loss measurements were conducted to 
evaluate the degradation of a PLDLA/TMC biodegradable mesh plate and screw over a two-year hydrolytic in 
vitro period. Thereafter, the clinical adequacy of these implants for converting an uncontained acetabular 
bone defect into a contained defect with a bone graft in the hip joint was evaluated for the first time in a 
clinical pilot study in selected osteoarthritic arthroplasty patients. 
 
The biomechanical test methods developed were successfully used to test the fixation properties of 
biodegradable bone fixation plate-screw constructs. The novel fixation method of having an osteosynthesis 
plate with cut-off screw heads provided equivalent biomechanical fixation properties to that obtained with 
conventional screw fixation over a 26-week period. The biodegradable ankle plate secured with 
biodegradable screws withstood simulated physiological cyclic loading and maintained simulated reduction of 
a lateral malleolar fracture over 12 weeks in vitro. Simulated physiological cyclic loading did not have any 
effect on the stability or inherent viscosity of the tested biodegradable implants. The biodegradable mesh 
plate retained most of its mechanical strength for eight weeks gradually losing it thereafter (completely by 26 
weeks). Less than 15 % of the initial inherent viscosity and mass of the implants remained after two years 
under hydrolytic in vitro conditions. In the clinical pilot study, a successful primary clinical radiological 
outcome was achieved and no resorbtion of the bone graft and no complications that could be related to the 
use of the implants under investigation were observed. 
 
To conclude, the biodegradable PLDLA/TMC bone fixation plate-screw constructs biomechanically tested in 
this study can be expected to provide sufficient fixation stability and the results of this study justify further 
clinical research with these devices and fixation methods. In addition, the biodegradable mesh plate and 
screws can be used for converting an uncontained acetabular bone defect into a contained defect to allow 
bone impaction grafting in selected osteoarthritic arthroplasty patients without resorting to the use of 
permanent graft containment hardware. These results justify further clinical research to investigate the 
feasibility of using the biodegradable PLDLA/TMC mesh plate and screws for more demanding defects. 
 
National Library of Medicine Classification: WE 185, QT 37.5.P7, WE 190, WE 103, WE 860, QT 37, QT 36 
Medical Subject Headings: Absorbable Implants; Hydrolysis; Orthopedic Fixation Devices; Bone Screws; 
Fracture Fixation; Materials Testing; Biomechanics; Polymers; Lactic Acid; Bone Plates; Surgical Mesh; 
Arthroplasty, Replacement, Hip; Viscosity; Bone Transplantation; Clinical Trial; In Vitro 
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PMMA  Polymethylmethacrylate 
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SS  Stainless steel 
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1 INTRODUCTION 
 
Bone fractures are some of the most common traumatic injuries. Operative treatment and internal 
fixation of bone fragments with some type of fixation implants are often required unless the 
fracture is stable and minimally displaced. The main function of the bone fixation implant is to 
maintain fracture reduction during bone healing. In addition, bone fixation implants are also used 
to maintain the relative position of bone grafts and in the treatment of various types of deformities 
of the skeleton. Metallic fixation devices such as pins, rods, wires, screws and plates have been 
extensively used for decades [265]. More recently, also implants made out of biodegradable 
polymers have been developed and clinically successfully used in the clinics for certain non-load 
and low-load bearing applications [43, 54, 61, 66-68, 83, 95, 146, 148, 156, 158, 171-172, 175, 
197, 201, 259, 271, 275, 288, 298, 304, 323, 332, 336, 348, 370, 374]. 
 
Traditional metallic fixation implants provide reliable and stable initial postoperative fixation 
allowing early mobilization but they and their permanent support become redundant and are often 
even harmful after consolidation [134, 138, 198, 209, 324, 345, 405-406]. The main disadvantage 
associated with metal implants is the frequent need for non-intended secondary surgical removal of 
hardware (e.g. due to implant migration, discomfort, pain, or stress shielding phenomena) [52, 
159, 172, 219, 324, 348]. The removal rate depends on the type of primary procedure and 
hardware used. For example, a secondary procedure for hardware removal after surgical treatment 
of lateral malleolar fracture, a typical fracture of the ankle, needs to be carried out in 16 % of cases 
already during the first postoperative year [268]. Furthermore, when rupture of the tibiofibular 
syndesmosis is treated with a metallic screw, the removal of hardware is usually done routinely in 
all cases 6-10 weeks postoperatively to enable normal movement of the ankle after healing [80, 
134, 175, 198, 324, 345, 348]. The main advantage and fundamental reason for developing 
implants made out of biodegradable materials is the avoidance of secondary removal of metallic 
hardware. In vivo, most of the biodegradable polymer materials degrade hydrolytically and are 
finally metabolized to water and CO2. In addition to the obvious advantage for the patients, the use 
of biodegradable implants instead of metallic hardware has been shown to reduce the overall costs, 
e.g. in ankle fracture cases by more than 20 % [56, 159], and their potential to reduce costs in other 
clinical applications has also been discussed [50, 52, 56, 159, 208, 398]. 
 
Before new fixation implants can be approved and adopted for clinical use, they need to be 
properly tested. Biomechanical in vitro testing and preclinical in vivo testing [1, 7, 15-16, 18, 22, 
24-25, 34, 37-38, 40, 44-46, 57, 63, 65, 71, 77, 80, 84, 96, 98, 100, 102, 106, 112-113, 116, 120, 
125, 128, 152, 154, 167, 173, 181, 184-185, 187-188, 195, 197, 214-215, 218, 221, 223, 226-227, 
229-230, 232, 234, 236, 241-242, 246, 251, 256-258, 263, 270, 280, 283, 285-287, 289-291, 296, 
301-302, 307-310, 312, 319-321, 326, 334, 337-340, 342, 346, 349-355, 361, 366, 372-373, 375-
378, 387, 389-390, 397, 399, 403, 408] are typically used in the determination and evaluation of 
the properties, performance and clinical adequacy of bone fixation implants. However, in contrast 
to the properties of conventional metallic implants, the properties of biodegradable implants are 
more dependent on testing conditions such as temperature and they tend to change over time 
during the healing period as a consequence of material degradation. Accordingly, testing of 
biodegradable bone fixation implants requires specific product and indication related 
considerations [1, 3, 17, 32, 40, 63, 72, 80-81, 84, 95-96, 117, 120, 125, 135, 138, 181, 219, 226-
227, 232, 236, 240, 247, 250, 257, 271, 278-282, 293, 302, 305, 307, 326, 331, 339, 342, 346, 357, 
361, 367, 369, 372-373, 387]. 
 
In this thesis, novel product- and indication-specific static and cyclic biomechanical test methods 
were developed and used to investigate the fixation properties of biodegradable bone fixation 
plate-screw constructs. In addition, after preliminary in vitro testing, a biodegradable mesh plate 
and screws were used clinically for the first time in a novel indication in the hip joint. 
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2 REVIEW OF THE LITERATURE 
 
Biodegradable polymer materials were introduced in surgical sutures over 40 years ago and the 
idea of using them for surgical implants was proposed as early as in 1966 by Kulkarni et al. [192]. 
The first biodegradable bone fixation implant was a biodegradable rod made out of polyglycolic 
acid (PGA). The world’s first orthopaedic patient treated with the biodegradable rods was an ankle 
fracture patient treated in Helsinki, Finland in 1984 [304]. Since then, there have been significant 
advances in the evolution of the biodegradable polymer materials, implants and their 
manufacturing methods. If one combines different materials, today it is possible to tailor the 
properties of the fixation implants according to indication-specific requirements e.g. regarding 
initial strength, strength retention and degradation time. Biodegradable materials other than 
polymers e.g. bioactive glass and hydroxyapatite also exist but have mainly been used as bone 
graft substitutes, most biodegradable bone fixation implants have been made out of polymer 
materials. 
 
 
2.1 Biodegradable polymer materials and implants 
 
The different biodegradable polymer materials, their biocompatibility and suitability for clinical 
use have been extensively studied during the past decades [24, 43, 53-54, 58, 61, 66-68, 83, 130, 
148, 150, 155, 158, 170-172, 187, 197, 229-230, 246, 251, 258-259, 266, 270, 272, 283, 298, 304, 
309, 322, 332, 334, 348, 353, 355, 366, 370-371, 374-376, 379]. According to a recent Cochrane 
Review [146], no significant difference between biodegradable and other implants exists with 
respect to functional outcome, infections and other complications. In addition, in some situations, 
reoperation rates were found to be significantly lower e.g. in case of ankle and wrist fractures 
treated with biodegradable implants. 
 
The first biodegradable orthopaedic fixation implants were made out of PGA (Fig. 1). PGA is a 
fairly strong material with sufficient strength retention rate for most fractures but since it is 
hydrophilic, from a biocompatibility point of view it degrades too quickly (completely within 6-12 
months) [360, 367]. The rapid degradation of the material causes a high amount of released 
degradation debris from the implant. When the amount of released debris exceeds the clearance 
capacity of the surrounding tissues, this often evokes an adverse tissue reaction (with an incidence 
up to 60 %) [51, 53, 58, 95, 129, 131, 133, 169, 274, 276, 282, 305]. Therefore, pure PGA is no 
longer considered to be suitable for larger volume orthopaedic implants. 
 
Since PGA was observed to degrade too rapidly for orthopaedic applications, much slower 
degrading polylactic acid (PLA) (Fig. 1) based poly-L-lactic acid (PLLA) became the next widely 
utilized material for orthopaedic fixation implants. The tissue reaction risk with lactic acid based 
implants has been reported to be very low during the first two years after the operation, only 0.2 % 
[9, 27, 33, 43, 53, 58, 134, 156, 323, 385] but unfortunately delayed tissue reactions have been 
observed several years later when the material finally degrades [33, 53, 58, 200, 381]. In this 
context, it should be noted that complete degradation of an implant made out of pure PLLA can 
take as long as ten years [17, 27, 33, 53, 58, 154, 200, 225, 234, 245, 292, 381, 385]. 
 
The rapid degradation of pure PGA and the slow degradation of pure PLLA implants eventually 
led to the utilization of co-polymers, i.e., combination of more than one type of polymer material, 
e.g. copolymers of L-lactic acid and PGA (PLGA), and L- and D-lactic acid (PLDLA) (Fig. 2). 
Instead of being made out of only L-lactic acid, the co-polymer materials contain also other 
polymer chains which disrupt the well-organized structure of pure L-lactic acid polymers. This 
type of more amorphous structure (in contrast to the high crystallinity of pure PLLA) permits 
faster complete hydrolytic degradation and elimination of the material than can be achieved with 
pure PLLA. The lactic acid based co-polymer materials typically degrade completely within 2-4 
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years which has proven to be adequate also from the biocompatibility point of view [53, 58, 151-
152, 160, 191, 223, 227, 257, 289, 336, 387]. The risk of postoperative tissue reactions after the 
use of PLDLA implants has been reported to be low, at least similar to that encountered with pure 
PLLA implants [32, 67, 75-76, 163, 191, 201, 207, 213, 219, 316, 357, 404-406]. Other material 
components have also been blended with PLA to improve and tailor the properties of the polymer 
based biodegradable implants, e.g. trimethylene carbonate (TMC) for rubber toughening of the 
material [219, 223, 342]. 
 
 
 
 
 
Figure 1. Structure of PGA and PLA polymers. 
 
 
 
  
 
 
Figure 2. Structure of L-, D- and DL-lactide (i.e., mesolactide), and PLA copolymer (PLDLA). 
 
 
There is currently a wide range of approved and clinically used biodegradable bone fixation 
implants commercially available including devices such as pins, rods, screws and plates [4-6, 9, 
19-21, 23, 28-30, 32-33, 35, 39, 42-43, 47-51, 53-55, 58, 60-61, 66-68, 74-76, 82-83, 86-92, 94-
95, 97-99, 101, 103-104, 109-112, 114-115, 119, 122-124, 127, 129, 131-135, 138, 144-148, 151, 
153, 156-159, 163-166, 169, 171-172, 175, 178, 183, 186, 190-191, 193-194, 196-199, 201, 205-
209, 213, 216, 219, 224, 228, 231, 233, 235, 237-239, 247, 252, 254-255, 259-260, 267, 269, 271, 
273-277, 284, 288, 293, 298, 304-305, 316-318, 323-325, 328, 332, 336, 341, 343, 345, 347-348, 
356-357, 368, 370, 374, 378, 380-382, 384, 388, 391, 394, 397-398, 400, 402, 404-407]. Most of 
these devices are PLA based. 
 
Biodegradable fixation implants have several advantages but also some disadvantages in 
comparison to conventional metallic implants. Most importantly, by using biodegradable implants, 
PGA PLA 
L-lactide D-lactide 
DL-lactide PLA-copolymer 
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secondary removal of hardware can usually be avoided. In addition, in contrast to metallic 
implants, the biodegradable implants do not cause imaging or radiotherapy interference, stress 
shielding, growth restriction, accumulation of metals in tissues, or secondary complications such 
as implant migration, discomfort, pain or infections after the implants have degraded. Furthermore, 
the biodegradable implants can be made to be malleable and easy to handle during operation, and 
possible revisions are usually easier to perform than if the previously implanted metallic hardware 
first needs to be removed [2, 6, 8, 26, 41, 52, 62, 95, 117, 123, 135, 137, 146-147, 149, 153, 172, 
174, 176-177, 179, 186, 189, 199, 202, 204, 208-210, 212-213, 224, 238, 243, 248-249, 253, 294, 
297, 299-300, 303-306, 311, 313, 315-317, 321, 325, 333, 336, 345, 348, 359, 362-365, 378, 392, 
400, 403-406]. However, because the biodegradable materials currently approved for human use 
obviously are not as strong as stainless steel (SS) or titanium (Ti) (Table 1), implants made out of 
these materials are usually mechanically weaker than conventional metallic fixation devices [265, 
282, 293]. Furthermore, in comparison to the metallic implants, the material properties of the 
biodegradable implants will change over the time period needed for bone healing. Therefore, a 
comparison of only the pure initial mechanical properties of the metallic and biodegradable 
implants is not sufficient. In addition, the properties of the biodegradable polymers (as well as any 
polymers and also metals generally), even if made out of the same raw material components, will 
clearly depend on their manufacturing processes (e.g. processing temperature, possible self-
reinforcing, sterilization method etc.) [17, 31, 59, 70, 72, 81, 93, 117, 217, 227, 245, 293, 305, 
342, 358-360, 372]. Conversely, this provides the possibility to develop materials and implants 
with distinctive desirable properties. However, this also means that differently manufactured 
products made out of the same raw material can have different product-specific properties such as 
different mechanical strengths and degradation behaviors [70, 245, 282, 293]. Therefore 
unambiguous data or conclusions about the properties of biodegradable products (or raw materials) 
cannot simply be based on test results obtained with other products made out of the same raw 
material if the detailed processing methods and parameters are not known. 
 
 
Table 1. Material properties of some clinically used implant materials and cortical bone [70, 117, 136, 
245, 265, 282, 359]. 
 
      In vivo loss times 
Material Tg (°C) 
Tm 
(°C) 
Modulus 
(GPa) 
Strength 
(MPa) 
Elongation 
(%) 
Strength 
(weeks) 
Mass 
(months) 
PGA 35-40 225-230 4.0-7.0 75-142 15-20 3-6 6-12 
PLLA 56-65 170-178 2.7-5.1 40-140 5-10 12-26 > 24 (up to 10 years) 
PLDLA 55-60 Amorphous 1.9 42-51 3-10 12-16 12-36 
SS (316L) – 1375-1400 200 550-965 20-50 – – 
Ti – 1650-1700 100 620 18 – – 
Cortical 
bone – – 3.3-17.0 51-193 1 – – 
 
 
Due to the obvious differences in the material properties of biodegradable implants in comparison 
to metal devices [282, 293], the biodegradable implants always need to be designed and tested in 
an indication-specific manner taking into consideration the product- and indication-specific 
conditions and requirements [1, 32, 63, 80-81, 84, 95, 117, 120, 125, 135, 138, 181, 219, 226, 247, 
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250, 271, 281-282, 293, 302, 307, 326, 331, 346, 357, 387], and they are usually not suitable for 
high-load bearing applications if not used in conjunction with traditional rigid fixation (e.g. 
fixation with metallic implants) or appropriate additional external immobilization (e.g. a plaster 
cast or splint) [4, 6, 43, 92, 134, 151, 153, 157, 159, 175, 191, 252, 273-274, 304, 323-324, 346-
347, 380]. On the other hand, their metallic counterparts can be considered to be stronger than that 
actually required for many of the non-load and low-load bearing applications. To achieve 
sufficient fixation stability, biodegradable bone fixation implant constructs, e.g. a plate secured 
with screws, typically need to be designed to be thicker and wider than the corresponding metal 
implants. The size of the biodegradable implants has led to complaints regarding the bulkiness and 
postoperative palpability of the implants [32, 58, 67-68, 87, 92, 138, 178, 201, 208-209, 219, 247, 
317, 400]. Furthermore, bulky and protruding large volume implants have been associated with a 
higher risk of postoperative tissue reactions than reduced-volume low-profile implants [92]. Other 
reported disadvantages of some biodegradable fixation implants are screw breakage during screw 
insertion, need for heating devices during the surgical operation, higher price, longer learning 
curve and operation time, and the need to be more careful with patient selection [5-6, 9, 32, 78, 
138, 199, 201, 208-209, 213, 219, 224, 271, 304, 330, 398, 400]. 
 
 
2.2 Degradation of biodegradable polymer materials and implants 
 
All lactic acid based biodegradable polymer implants degrade through hydrolysis (Fig. 3-4). First 
water penetrates the implant and the process of degradation continues with the polymer chains 
being broken into smaller fragments by hydrolysis. As a result, the molecular weight of the 
implant starts to decrease (leading to a reduction in the inherent viscosity, which represents a 
reduction in its molecular weight) until a sufficient number of the polymer chains have been 
broken so that also the mechanical strength of the material is affected. Thereafter, also the 
mechanical strength of the implant starts to decrease allowing subsequent mechanical 
fragmentation and the initiation of the absorption of the implant ultimately leading to actual mass 
loss of the implant. The actual mass loss of the implant occurs due to release of soluble 
degradation products, phagocytosis by macrophages and histiocytes, intracellular degradation, and 
finally, metabolic elimination through the citric acid (Krebs) cycle to carbon dioxide (CO2) and 
water, and the metabolic end products are expelled from the body via respiration and urine [9, 16, 
31, 117, 121, 135, 223, 227, 245, 271, 281-282, 293, 335-336].  
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Figure 3. The hydrolytic degradation of the PGA and PLA polymers (or their copolymers) in vivo 
yields to glycolic acid and lactic acid monomers. Ultimately, monomers enter citric acid cycle for 
further metabolism, yielding energy, CO2 (which is excreted by the lungs) and water. Enzymes, free 
radicals and immune cells have also several roles in the degradation [16, 271, 335-336]. 
 
 
 
 
Figure 4. Hydrolytic degradation of the PLA. 
 
 
The overall degradation time of a biodegradable implant depends on several factors i.e., those 
dependent on the material and implant itself (e.g. hydrophilic vs. hydrophobic material, polymer 
structure/crystallinity, initial molecular weight, ratios of co-polymer’s components, implant’s size 
and design, and material processing, manufacturing and sterilization methods) [17, 31, 53, 70, 72, 
79, 117, 121, 135, 200, 227, 245, 250, 281-282, 293, 342, 359, 372-373], implantation site (inside 
vs. outside bone, thickness of the covering soft tissue layer, and local vascularity/blood circulation 
and temperature) and inter-individual differences of patients [3, 9, 16, 36, 53, 58, 160, 191, 197, 
279, 282, 354, 373]. Optimally, after complete degradation of the biodegradable implant, any 
remaining cavities in the bone will be filled by new bone. However, the findings regarding implant 
replacement by bone have so far been somewhat contradictory. There are studies which seem to 
indicate that biodegradable implants are eventually replaced by bone [27, 203, 249, 289] whereas 
some investigators have concluded that this is not the case [105, 161, 202, 231, 289, 393]. It 
should be noted that as lactic acid based implants are not surface eroding [79, 182] they cannot be 
replaced by bone before complete degradation of the material has occurred. Accordingly, each 
material needs to be studied separately and the follow-up must be longer than the expected 
degradation time of the material (e.g. more than 10 years for implants made out of pure PLLA). 
 
Lactic acid 
PGA 
PLA 
CO2 
Glyoxylate 
Glycine 
Serine 
Oxalic acid 
Excreted in urine 
Pyruvic acid 
Acetyl CoA 
Glycolic acid 
CO2 + H2O 
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As described above, the degradation of lactic acid based biodegradable implants occurs in 
sequential, overlapping phases: molecular weight decreases initially, and this is followed by a 
reduction in mechanical strength and finally also the actual mass of the implant is lost. This phased 
progress needs to be considered when degradation properties of lactic acid based biodegradable 
implants are evaluated. Instead of focusing only on the total degradation time of the implant, it is 
also important to consider the strength retention rate of the implant and to compare it to the 
indication-specific strength requirements, i.e., how much strength is needed and for how long is it 
needed with respect to the expected healing time. 
 
The risk of postoperative adverse tissue reactions always exists when foreign materials are 
implanted in patients [53, 58]. All biodegradable implants induce a subclinical (i.e., non-
symptomatic) but microscopically recognizable non-specific foreign body type of tissue response 
[305]. This is to be expected and can be considered as normal as long as it does not evoke any 
clinical symptoms. Clinical symptoms can occur if the degradation rate is faster than the body’s 
ability to handle the degradation products (i.e., either tolerate or eliminate) and thus the role of 
local vascularity becomes important in the elimination phase of the degradation. Optimally, the 
degradation should not occur too quickly but nonetheless fast enough to provide a clinical benefit, 
it should be possible to tailor the degradation rate to be indication-specific, and the degradation 
process should be a controlled, steady/gradual process without any clear degradation peaks. The 
tissue reaction risk is highest when the gross geometry of the implant is lost (i.e., when the actual 
mass loss of the implant occurs). Accordingly, the risk of symptomatic tissue reactions is high if 
the implant is very large and/or made out of a material that degrades in an uncontrolled or sudden 
manner [53, 58, 70, 245]. The risk is also higher if the implants are bulky (e.g. high volume plates 
with protruding screw heads) than in the case of low volume and low profile devices [92]. It 
should be noted that tissue reactions are possible even with very slow degrading materials if the 
final breakdown of the material happens in an uncontrolled or abrupt manner [200, 381]. Local 
vascularity is generally better inside than outside the bone. Accordingly, the risk of tissue reactions 
is lower inside than outside the bone because it is directly related to the clearing capacity of the 
surrounding tissues. Additionally, the risk of postoperative tissue reactions is higher after 
implantation under a thin soft tissue layer than if the implant is covered by a thick tissue layer [9, 
58].  
 
It is important not to confuse the above discussed degradation related tissue reactions with the 
normal physiological responses to any implantation or surgery. All implantations and even surgery 
itself provoke some degree of tissue injury, which induces a physiological healing response. This 
consists of two essential components: inflammation and repair processes that represent a spectrum 
of interdependent molecular and cellular responses. The implant’s foreign nature tends to trigger a 
chronic inflammatory response characterized by a granulomatous reaction. Acute inflammation 
can be superimposed and be especially marked if a bacterial infection should be present at the 
same time [180]. The number of bacterial infections has been shown to be non-material related and 
to be equivalent after implantation of metal and biodegradable materials [322-323]. 
 
 
2.3 Testing of biodegradable polymer materials and bone fixation implants 
 
The adequacy of new bone fixation implants needs to be demonstrated prior to their approval by 
authorities and clinical adoption by surgeons. This is typically done by conducting in vitro testing, 
preclinical in vivo testing and clinical testing. 
 
 
2 - Review of the literature 
 
23 
2.3.1 In vitro testing 
 
The in vitro testing of bone fixation implants typically consists of testing of mechanical and 
biomechanical properties. It is common that the adequacy of new biodegradable bone fixation 
implants is determined by comparing their mechanical and biomechanical properties and behavior 
to those of other similar previously approved and clinically successfully used fixation devices with 
the same intended use, either metallic [1, 7, 22, 25, 40, 44-45, 63, 71, 80, 84, 102, 106, 120, 125, 
128, 173, 181, 188, 214-215, 226, 232, 280, 287, 290, 293, 295, 301-302, 307-308, 310, 319, 326, 
346, 387, 390, 399, 408] or biodegradable [22, 44-46, 102, 125, 128, 173, 218, 226, 287, 301, 349-
350, 352, 387, 390, 399]. When no such appropriate control device exists, the adequacy can be 
evaluated by testing the ability of the device to withstand simulated indication-specific 
physiological loading conditions [1, 7, 22, 63, 80, 84, 100, 102, 125, 226, 293, 320, 326, 346]. In 
clinical use, bone fixation implant constructs and their components are most commonly under 
tension, compression, bending, shear and torsion type of loading (or their combinations). The 
loading can be either static, cyclic or a combination of those [1, 7, 22, 40, 63, 69, 71, 73, 80, 84, 
100, 102, 106, 120, 125, 128, 173, 181, 214-215, 226, 280-281, 290, 293, 302, 307, 310, 320, 326, 
346, 387, 390, 408]. 
 
In the testing of mechanical properties, the pure mechanical properties of a bone fixation implant 
alone are determined e.g. by tensile, compression, bending, shear and torsion tests [69, 72, 81, 145, 
227, 236, 240, 250, 257, 278, 295, 331, 339, 342, 360-361, 367, 372-373] but in that case, the 
actual fixation properties and behavior of the implant or implant construct cannot be reliably 
investigated. In biomechanical testing, a complete simulated fixation test specimen, i.e., simulated 
bone fragments fixed with a fixation implant or implants (e.g. several screws or a plate secured 
with screws), is tested (Table 2). Accordingly, the results of biomechanical testing reflect the 
actual fixation properties and behavior of the bone fixation implants. Although mechanical 
properties testing can provide valuable information, biomechanical testing is usually considered as 
being clinically more relevant.  
 
Human cadaver bones have been widely used in biomechanical testing of biodegradable bone 
fixation implants [63, 80, 106, 125, 128, 173, 181, 214-215, 218, 232, 287, 290, 307, 320, 326, 
346, 349-350, 352, 387] and obviously they provide the most realistic in vitro testing model. 
However artificial materials such as polyurethane (PU) foam blocks and PU artificial bones [22, 
25, 40, 96, 100, 116, 188, 280], wood [301] and polymethylmethacrylate (PMMA) [44-46] have 
also been used as the carrier materials in biomechanical testing of biodegradable bone fixation 
implants. The existing test standards for metallic fixation implants recommend the use of 
substitute materials such as PU and polyethylene (PE) [10-11, 13, 143]. In addition, animal bones 
are also widely used [7, 71, 84, 102, 226, 308, 310, 390, 399, 408]. 
 
Both mechanical properties and biomechanical testing of biodegradable bone fixation implants can 
be carried out by using either static [7, 17, 22, 40, 45-46, 71-72, 84, 96, 102, 106, 120, 125, 128, 
145, 173, 214-215, 218, 227, 232, 236, 240, 250, 257, 278, 280, 287, 295, 301-302, 307-308, 310, 
339, 342, 349-350, 352, 360-361, 367, 372-373, 387, 390, 399, 408] or cyclic loading [1, 63, 69, 
80-81, 100, 181, 226, 290, 320, 326, 331, 346]. In static tests, the test specimen is typically loaded 
at a constant speed or is placed under increasing load until failure of the specimen [1, 22, 40, 45-
46, 96, 100, 120, 125, 128, 173, 214-215, 218, 226, 257, 280, 307-308, 349-350, 352, 387, 390, 
399] or until a preset limit is achieved [1, 7, 45-46, 84, 102, 106, 232, 307, 408]. In a cyclic test, 
the specimen is placed under several sequential displacement controlled or force controlled 
loading cycles [1, 63, 69, 80-81, 100, 181, 226, 290, 320, 326, 331, 346]. In clinical use, most 
bone fixation implants or implant constructs are under a cyclic type of loading even in non-load 
and low-load bearing applications [40, 69, 80, 280-281, 346, 390]. Accordingly, static testing 
alone does not allow one to draw conclusions regarding the implants’ clinical adequacy [1, 40, 69, 
80, 106, 120, 125, 135, 218, 280-281, 302, 307, 326, 329, 331, 346, 349-350, 390]. However, even 
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in the case of cyclic testing, the clinical relevance of the results depends greatly on the in vitro test 
model’s ability to simulate the actual indication-specific physiological loading conditions.  
 
The relationship between a load applied to test specimen and the corresponding displacement (i.e., 
deformation) values during testing can be depicted as the load-displacement curve (Fig. 5). The 
curve typically has two regions: the elastic and plastic deformation regions. In the elastic region, 
the displacement increases linearly when load increases. The slope of the load-displacement curve 
in the elastic region represents the initial stiffness or rigidity of the specimen being tested. The 
yield point separates the elastic and plastic regions. The yield point can be defined as the first point 
on the load-displacement curve at which the increase in displacement occurs without any increase 
in load [14] or as the point at which the slope of the load-displacement curve first clearly decreases 
[261]. If the load (or displacement) applied is below the yield point, the load does not cause any 
permanent damage to specimen (if the load is terminated). If the load applied is above the yield 
point, then the specimen will experience permanent damage (i.e., plastic region). In the plastic 
region, the slope of the curve starts to decline but the load continues to increase to the maximum 
point (and finally until breakage of the specimen) [59, 93, 136, 386]. Due to the viscoelastic 
behavior of biodegradable materials, the load at the final failure point can actually be lower than at 
the actual maximum point (or even at the yield point). In general terms, the yield point can be 
considered to be the most relevant point of “failure” in the clinical setting. 
 
 
 
 
Figure 5. Schematic illustration of a load-displacement curve [modified from 14, 59]. The yield point 
can be defined as the first point on the load-displacement curve at which the increase in displacement 
occurs without any increase in load [14] or as the point at which the slope of the load-displacement 
curve first clearly decreases [261]. 
 
 
As mentioned, one issue relating to testing of biodegradable fixation implants (and their behavior) 
is the viscoelastic behavior and how this affects the properties of the materials. A viscoelastic 
material exhibits both viscous and elastic characteristics when subjected to loading. With high 
temperature or slow loading speeds, a viscoelastic material behaves like a solid liquid, i.e., 
viscously. If the temperature is low or the loading speed high, viscoelastic material behaves 
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elastically (and finally plastically) like e.g. metals. When loading is applied, a viscous (and elastic) 
material resists load and deformation linearly over a certain period of time. An elastic material 
experiences instantaneous deformation when loaded and quickly returns to its initial state when the 
loading is terminated [59, 93, 282]. 
 
In studies with static mechanical properties testing, yield and maximum strength, and modulus 
values for the biodegradable bone fixation implants and implant materials have commonly been 
reported as result parameters [17, 69, 72, 145, 154, 185, 197, 227, 236, 240, 278, 286, 291, 339, 
342, 360-361, 367, 372-373]. Strength and modulus values (MPa or GPa) enable a direct 
comparison of the mechanical properties of different materials. However, the strength values 
cannot be commonly used as result parameters in biomechanical testing (or mechanical properties 
testing if the implant has a very complex design) because there are several surfaces and interfaces 
between the parts of the implants (e.g. screw head and plate surface, screw threads etc.) and also 
between the implant and the carrier material which are influenced by loading forces and thus the 
actual effective surface areas and interfaces cannot be unambiguously determined in terms of a 
strength value or modulus calculations. On the contrary, in biomechanical testing, measurement of 
direct loading forces (and displacements) does not provide detailed information about material 
properties per se but reveals how much loading the complete simulated fixation test specimen (i.e., 
simulated bone fragments fixed with a fixation implant or implants) can withstand. Therefore, 
direct, measured load, displacement or stiffness values (N, mm and N/mm) have been most 
commonly reported as result parameters in studies with pure static biomechanical testing [7, 22, 
40, 45-46, 71, 84, 93, 96, 102, 120, 125, 128, 173, 214-215, 218, 232, 280, 287, 301, 307-308, 
310, 349-350, 352, 399, 408].  
 
As mentioned above, even though a cyclic type of loading is almost always present clinically, 
there have been very few cyclic mechanical and biomechanical studies conducted with 
biodegradable bone fixation implants [1, 63, 69, 80-81, 100, 181, 226, 290, 320, 326, 331, 346] 
and in most of the studies only static testing has been conducted [7, 17, 22, 40, 45-46, 71, 84, 96, 
102, 106, 120, 125, 128, 145, 154, 173, 185, 197, 214-215, 218, 227, 232, 236, 240, 250, 257, 278, 
280, 286-287, 291, 295, 301-302, 307-308, 310, 339, 342, 349-350, 352, 360-361, 367, 372-373, 
387, 390, 399, 408]. Thus also the data about the behavior of biodegradable materials and implants 
under cyclic loading is very limited. 
 
The loading protocol for biodegradable bone fixation implants in cyclic tests is normally based on 
some prior defined maximum failure load or on displacement values of the implant [69, 81, 331] 
or alternatively by some estimated indication-specific physiological loading condition [1, 63, 80, 
100, 226, 320, 326, 346]. No test standards exist for cyclic testing of biodegradable bone fixation 
implants but the current test standards for cyclic testing of metallic implants [10, 143] state that 
one should use loads based on the maximum initial strength of the implants. Furthermore, also the 
currently used test standards for testing of total hip replacements define the test methods based on 
the physiological conditions, i.e., temperature, walking speed, loadings in hip during walking etc. 
[139, 142, 162, 211, 222]. However, it must be noted that the fundamental concept behind the total 
hip replacements and metallic spinal implant constructs is totally different from that for their 
biodegradable counterparts. The former needs to withstand the loadings and clinical conditions 
without failure as long as possible and the latter only for as long as needed. Irrespective of the 
approach, the cyclic testing of biodegradable bone fixation implants is normally run until failure of 
the specimen [10, 69, 81, 100, 143, 320] or until achieving a preset amount of loading cycles [1, 
10, 63, 80, 139, 142, 181, 226, 290, 320, 326, 331, 346]. The amount of loading cycles in previous 
studies investigating biodegradable bone fixation implants has varied from five [181] up to as 
many as one million cycles [69]. 
 
In cyclic (and also in static) biomechanical testing, the testing outcome is more or less a 
combination of the properties of the fixation implants and the carrier materials being used (i.e., the 
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whole test specimen) whereas in mechanical property testing, the actual material properties of the 
implants can be evaluated. Therefore, in biomechanical testing, the effect of different parts of the 
test specimen on the result parameters is very difficult to determine unequivocally. Therefore, a 
common outcome and result of cyclic biomechanical testing is that the test specimen either 
withstands or fails under certain loading conditions over a given time [100, 320, 326, 346] which 
can be sufficient if the test protocol is truly representative of the clinical situation. In addition, 
cyclic loading induced changes in stiffness or displacement of the test specimen are commonly 
reported [1, 63, 80, 181, 226, 290, 326, 346]. 
 
In several previous biomechanical studies investigating the biodegradable bone fixation implants, 
no detailed test conditions have been unambiguously described [1, 7, 22, 63, 71, 80, 84, 102, 106, 
120, 125, 128, 173, 181, 214-215, 218, 226, 287, 290, 301-302, 310, 320, 326, 349-350, 352, 390, 
399, 408], though most probably the conditions in those studies have been in dry conditions at 
room temperature (RT). Furthermore, typically biomechanical testing of biodegradable bone 
fixation implants has also been focused on the determination of initial properties [1, 7, 22, 45-46, 
63, 71, 80, 84, 100, 102, 106, 120, 125, 128, 173, 214-215, 218, 226, 287, 290, 301-302, 307-308, 
310, 320, 346, 349-350, 352, 387, 390, 399, 408]. These are not issues in the testing of 
corresponding metallic implants (intended for the same application) because normally their 
properties are not affected by temperature or moisture (or even loading) over the time needed for 
bone healing. However, the properties of biodegradable materials are dependent on the 
surrounding conditions (and time), and those need to be taken into account when evaluating the 
clinical suitability of a biodegradable fixation implant. In some studies, biodegradable implants 
have been moistened or kept wet during testing, or the implants have been tested immediately after 
their removal from wet conditions [106, 108, 307, 387]. At present, there are only five 
biomechanical studies were the initial properties of the biodegradable fixation implants have been 
investigated at body temperature and under wet conditions, i.e., immersed into water or saline 
solution [45-46, 100, 308, 346]. 
 
Compared to corresponding biodegradable implants, conventional metallic bone fixation implants 
usually retain their properties unchanged over the typical time window required for bone healing. 
Accordingly, the testing of their initial mechanical and biomechanical properties will usually 
suffice. However, since the mechanical and biomechanical properties of biodegradable implants 
tend to change over time due to the material degradation, it is obvious that only testing and 
determination of their initial properties is not sufficient for demonstrating their suitability for 
clinical use. In order to investigate the in vitro properties and behavior of biodegradable implants 
over time, hydrolytic conditions need to be utilized by incubating the implants under wet 
conditions, e.g. in phosphate buffer solution (PBS), at the body temperature of 37 °C throughout 
the investigation period [17, 40, 72, 81, 96, 100, 181, 227, 232, 236, 240, 250, 256-257, 278, 280, 
331, 339, 342, 360-361, 367, 372-373]. The methods for achieving hydrolytic in vitro degradation 
conditions for biodegradable materials and implants are also described in the existing material test 
standards [140-141]. In addition to investigating the retention of the mechanical and 
biomechanical properties over time, also the changes in the other material properties, e.g. inherent 
viscosity, mass loss and thermal properties (representing actual hydrolytic in vitro degradation of 
the implant material), can be investigated in vitro [3, 17, 72, 140-141, 227, 236, 240, 250, 256-
257, 279, 339, 342]. Traditionally, when biodegradable bone fixation implants have been 
investigated over time and under hydrolytic in vitro conditions, only the mechanical [17, 72, 81, 
227, 236, 240, 250, 257, 278, 331, 339, 342, 360-361, 367, 372-373], not the biomechanical 
properties, have been examined. In some of these in vitro studies with hydrolytic in vitro 
conditions, the actual testing, however, has been carried out under dry conditions at RT [72, 227, 
360, 372-373].  
 
There are only four previously published static biomechanical studies [40, 96, 232, 280] and only 
one cyclic biomechanical study [181] which have investigated biodegradable bone fixation 
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implants over time using hydrolytic in vitro conditions. PU foam blocks and bone models were 
used to simulate human bone in three of the static studies [40, 96, 280] whereas Maruyama et al. 
(1996) and Klos et al. (2009) used human cadaver bones [181, 232]. In the studies with PU foam, 
the duration of the hydrolytic degradation period was 6-12 weeks. Pietrzak et al. (2006) arranged 
their hydrolytic in vitro conditions at an elevated temperature leading to accelerated degradation 
[280] as previously also described by others [3, 72, 279]. In the study of Maruyama and co-
workers, testing was conducted for up to four weeks by which time all of the specimens had lost 
their mechanical stability. It must be noted that Maruyama et al. did not prepare separate 
specimens for each testing time point, instead they tested the same specimens repeatedly at 14 
different time points. The duration of the hydrolytic in vitro period in the study of Klos et al. was 
six weeks. Neither Maruyama et al. nor Klos et al. reported any details about the quality of the 
cadaver bones after four or six weeks’ incubation under hydrolytic in vitro conditions but it can be 
speculated that several weeks’ incubation at 37 °C under wet conditions must have had some 
effect on the properties of the cadaver bones. It is unlikely that cadaver bones would tolerate 
hydrolytic conditions for such a long time period without any changes in their properties due to 
decomposition. 
 
Despite the significant role of degradation and cyclic loading in determining the clinical behavior 
of the biodegradable fixation implants, only two studies, in addition to the study of Klos et al. 
(2009) [181], can be found in which both properties have been incorporated into the test protocol 
[81, 331]. However, these studies with a six-week hydrolytic in vitro period, tested only the 
mechanical not the biomechanical consequences of the incubation. Furthermore, the number of 
loading cycles in the study of Klos et al. was only five. 
2 - Review of the literature 
 
28 
Pa
ra
m
et
er
s 
Cy
cl
ic
: 
st
iff
 
St
at
ic
: 
di
sp
 
at
 
m
ax
 
lo
ad
 
Lo
ad
 
at
 
1.
75
 
an
d 
3.
5 
m
m
 
di
sp
 
St
iff
,
 
fa
ilu
re
 
lo
ad
 
an
d 
di
sp
, 
fa
ilu
re
 
m
o
de
 
St
iff
,
 
fa
ilu
re
 
lo
ad
,
 
fa
ilu
re
 
m
o
de
 
St
iff
,
 
m
ax
 
lo
ad
 
St
iff
,
 
m
ax
 
lo
ad
 
St
ra
in
 
at
 
ea
ch
 
cy
cl
e 
L
o
a
di
n
g 
pr
o
to
co
l 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l 
St
at
ic
: 
co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
 
o
r 
15
00
 
N
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(up
 
to
 
3.
5 
m
m
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
 
o
r 
u
p 
to
 
16
0°
 
in
 
to
rs
io
n
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
 
o
r 
u
p 
to
 
16
0°
 
in
 
to
rs
io
n
) 
Lo
ad
 
co
n
tr
o
l, 
ph
ys
io
lo
gi
ca
l 
T
es
tin
g 
m
et
ho
d 
Lo
ad
s 
ap
pl
ie
d 
to
 
hi
p 
al
o
n
g 
fe
m
u
r 
3-
p 
be
n
di
n
g 
sim
u
la
tin
g 
m
as
tic
at
io
n
 
lo
ad
s 
A
n
t-
po
st
 
an
d 
in
f-s
u
p 
lo
ad
s 
4-
p 
be
n
di
n
g 
Te
n
sil
e,
 
to
rs
io
n
,
 
sid
e 
be
n
di
n
g 
Te
n
sil
e,
 
to
rs
io
n
,
 
sid
e 
be
n
di
n
g 
Lo
ad
in
g 
o
f 
ip
sil
at
er
al
 
m
o
la
r 
T
yp
e 
o
f 
lo
a
di
n
g 
Cy
cl
ic
 
(10
 
cy
cl
es
) 
an
d 
st
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
Cy
cl
ic
 
(10
 
cy
cl
es
) 
T
es
tin
g 
co
n
di
tio
n
s 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
37
.
2 
°
C 
w
at
er
 
37
.
2 
°
C 
w
at
er
 
N
o
t 
m
en
tio
n
ed
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
–
 
–
 
–
 12
 
w
ks
 
at
 
37
.
3 
°
C 
PB
S,
 
pH
 
7.
4 
24
 
h 
at
 
37
.
2 
°
C 
w
at
er
 
24
 
h 
at
 
37
.
2 
°
C 
w
at
er
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
Co
m
po
sit
e 
O
v
in
e 
bo
n
e 
PU
 
Sy
n
th
et
ic
 
bo
n
e 
PM
M
A
 
PM
M
A
 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
M
o
de
l 
A
ce
ta
bu
la
r 
fra
ct
u
re
 
M
an
di
bu
la
r 
fra
ct
u
re
 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
H
an
d 
fra
ct
u
re
 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
M
an
di
bu
la
r 
fra
ct
u
re
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
Sc
re
w
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
an
d 
m
es
h 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
–
 Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Im
pl
a
n
t  
PL
LA
 
sc
re
w
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
(m
at
er
ia
l n
o
t 
m
en
tio
n
ed
) 
PL
G
A
 
pl
at
e 
an
d 
m
es
h 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
A
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
G
A
, 
PL
D
LA
,
 
an
d 
PL
D
LA
/T
M
C 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
D
LA
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
an
d 
pi
n
s 
PL
D
LA
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Ta
bl
e 
2.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
A
da
m
cz
yk
 
et
 
al
.
 
[1
] 
A
lk
an
 
et
 
al
.
 
[7]
 
A
ra
u
jo 
et
 
al
.
 
[22
] 
B
o
zi
c 
et
 
al
.
 
[4
0]
 
B
u
ijs
 
et
 
al
.
 
[4
5]
 
B
u
ijs
 
et
 
al
.
 
[4
6]
 
Ch
ac
o
n
 
et
 
al
.
 
[63
] 
2 - Review of the literature 
 
29 
Pa
ra
m
et
er
s 
St
iff
,
 
m
ax
 
fo
rc
e 
an
d 
di
sp
, 
di
sp
 
at
 
lo
ad
s 
20
, 
60
, 
12
0 
an
d 
15
0 
N
 
Cy
cl
ic
: 
st
iff
 
St
at
ic
: 
fa
ilu
re
 
to
rq
u
e 
an
d 
an
gl
e 
St
iff
,
 
di
sp
 
at
 
lo
ad
s 
w
ith
 
st
ep
 
o
f 
10
 
N
 
Pe
ak
 
fa
ilu
re
 
lo
ad
,
 
fa
ilu
re
 
m
o
de
 
St
at
ic
: 
pe
ak
 
lo
ad
,
 
st
ra
in
 
at
 
yi
el
d 
Cy
cl
ic
: 
cy
cl
es
 
to
 
fa
ilu
re
 
D
isp
 
at
 
lo
ad
s 
w
ith
 
st
ep
 
o
f 1
0 
N
 
R
ig
id
ity
 
L
o
a
di
n
g 
pr
o
to
co
l 
Co
n
st
 
sp
ee
d 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l 
St
at
ic
: 
co
n
st
 
lo
ad
 
(ax
ia
l c
o
m
p) 
an
d 
co
n
st
 
sp
ee
d 
(ro
t),
 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(up
 
to
 
14
0 
N
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
St
at
ic
: 
co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l, 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(up
 
to
 
10
0 
N
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
 
(up
 
to
 
10
 
o
r 
25
 
N
) 
Te
st
in
g 
m
et
ho
d 
Te
n
sio
n
 
sim
u
la
tin
g 
m
as
tic
at
io
n
 
lo
ad
s 
Cy
cl
ic
: 
ax
ia
l 
co
m
p 
St
at
ic
: 
ax
ia
l 
co
m
p 
an
d 
ro
t 
B
io
m
ec
h 
v
er
tic
al
 
lo
ad
in
g 
Sh
ea
r,
 
pu
llo
u
t 
St
at
ic
: 
te
n
sil
e 
Cy
cl
ic
: 
sim
u
la
tin
g 
m
as
tic
at
io
n
 
lo
ad
s 
Ca
n
t 
be
n
di
n
g 
To
rs
io
n
,
 
4-
p 
ap
ex
 
pa
lm
ar
 
be
n
di
n
g,
 
ax
ia
l c
o
m
p 
T
yp
e 
o
f 
lo
a
di
n
g 
St
at
ic
 
Cy
cl
ic
 
(10
00
 
cy
cl
es
) 
an
d 
st
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
an
d 
cy
cl
ic
 
(av
er
ag
e 
34
06
75
 
cy
cl
es
) 
St
at
ic
 
St
at
ic
 
Te
st
in
g 
co
n
di
tio
n
s 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
St
at
ic
: 
R
T,
 
dr
y 
Cy
cl
ic
: 
37
 
°
C 
w
at
er
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
–
 
–
 
–
 8 
w
ks
 
at
 
37
 
°
C 
PB
S,
 
pH
 
7.
4 
–
 
–
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
O
v
in
e 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
O
v
in
e 
bo
n
e 
PU
 
su
bs
tr
at
e 
U
re
th
an
e 
O
v
in
e 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
M
o
de
l 
M
an
di
bu
la
r 
fra
ct
u
re
 
Sy
n
de
sm
o
si
s 
in
jur
y 
M
an
di
bu
la
r 
fra
ct
u
re
 
Im
pl
an
t’
s 
fix
at
io
n
 
M
an
di
bu
la
r 
fra
ct
u
re
 
M
an
di
bu
la
r 
fra
ct
u
re
 
Fi
n
ge
r 
fra
ct
u
re
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
Sc
re
w
 
Sc
re
w
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
–
 
–
 Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
K
-
w
ire
 
Im
pl
a
n
t 
PL
G
A
 
sc
re
w
 
PL
G
A
 
sc
re
w
 
PL
G
A
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
G
A
 
ta
ck
 
PL
G
A
 
sc
re
w
 
PL
D
LA
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PG
A
 
pi
n
 
Ta
bl
e 
2 
-
 
co
n
t’
d.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
Ci
la
su
n
 
et
 
al
.
 
[7
1]
 
Co
x
 
et
 
al
.
 
[8
0]
 
D
o
la
n
m
az
 
et
 
al
.
 
[84
] 
Ep
pl
ey
 
an
d 
Pi
et
rz
ak
 
[9
6]
 
Ep
pl
ey
 
et
 
al
.
 
[1
00
] 
Es
en
 
et
 
al
.
 
[1
02
] 
Fi
to
u
ss
i e
t 
al
.
 
[10
6]
 
2 - Review of the literature 
 
30 
Pa
ra
m
et
er
s 
Fa
ilu
re
 
lo
ad
 
Fa
ilu
re
 
lo
ad
 
St
iff
,
 
u
lti
m
at
e 
lo
ad
 
an
d 
di
sp
 
Fa
ilu
re
 
lo
ad
,
 
fa
ilu
re
 
m
o
de
 
Cy
cl
ic
: 
st
iff
 
an
d 
n
eu
tr
al
 
zo
n
e 
St
at
ic
: 
 
de
fo
rm
at
io
n
 
at
 
10
0 
N
 
(or
 
lo
ad
 
at
 
fa
ilu
re
) 
St
iff
,
 
u
lti
m
at
e 
lo
ad
 
an
d 
di
sp
 
St
iff
,
 
u
lti
m
at
e 
fo
rc
e 
an
d 
di
sp
 
M
ax
 
lo
ad
,
 
fa
ilu
re
 
m
o
de
 
Cy
cl
ic
: 
to
ta
l 
de
fo
rm
at
io
n
 
an
d 
st
iff
 
St
at
ic
: 
fa
ilu
re
 
lo
ad
 
L
o
a
di
n
g 
pr
o
to
co
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
), 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l 
St
at
ic
: 
co
n
st
 
lo
ad
 
(up
 
to
 
10
0N
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l, 
ph
ys
io
lo
gi
ca
l 
St
at
ic
: 
co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Te
st
in
g 
m
et
ho
d 
B
io
m
ec
h 
di
st
ra
ct
io
n
 
an
d 
co
m
p 
B
io
m
ec
h 
m
as
se
te
ric
 
pu
ll 
B
io
m
ec
h 
co
m
p 
B
io
m
ec
h 
be
n
di
n
g 
Cy
cl
ic
: 
m
ed
la
t 
be
n
di
n
g,
 
to
rs
io
n
 
St
at
ic
: 
m
ed
la
t 
be
n
di
n
g 
B
io
m
ec
h 
be
n
di
n
g 
B
io
m
ec
h 
be
n
di
n
g 
Pu
llo
u
t 
Cy
cl
ic
: 
lo
ad
 
ac
ro
ss
 
joi
n
t 
su
rf
ac
e 
St
at
ic
: 
te
n
sil
e 
v
ia
 
lig
am
en
t 
T
yp
e 
o
f 
lo
a
di
n
g 
St
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
Cy
cl
ic
 
(5 
cy
cl
es
) 
an
d 
st
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
Cy
cl
ic
 
(20
0 
cy
cl
es
) 
an
d 
st
at
ic
 
Te
st
in
g 
co
n
di
tio
n
s 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
–
 
–
 
–
 
–
 6 
w
ks
 
at
 
37
 
°
C 
PB
S,
 
pH
 
7.
4 
–
 
–
 
–
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
O
v
in
e 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
B
o
v
in
e 
bo
n
e 
M
o
de
l 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
Fo
o
t 
fra
ct
u
re
 
M
ax
ill
o
-
fa
ci
al
 
fra
ct
u
re
 
A
n
kl
e 
fra
ct
u
re
 
Fo
o
t 
fra
ct
u
re
 
Fo
o
t 
fra
ct
u
re
 
Im
pl
an
t 
fix
at
io
n
 
Ti
bi
al
 
fra
ct
u
re
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Sc
re
w
,
 
pi
n
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pi
n
 
Sc
re
w
 
–
 Sc
re
w
 
Im
pl
a
n
t 
PL
G
A
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
G
A
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
LA
 
sc
re
w
 
an
d 
pi
n
 
PL
G
A
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
D
LA
/T
M
C 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PG
A
 
pi
n
 
PL
LA
 
sc
re
w
 
PL
D
LA
 
sc
re
w
 
an
d 
ta
ck
 
Sc
re
w
,
 
n
ai
l 
(m
at
er
ia
l n
o
t 
m
en
tio
n
ed
) 
Ta
bl
e 
2 
-
 
co
n
t’
d.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
G
o
sa
in
 
et
 
al
.
 
[1
20
] 
H
an
em
an
n
 
et
 
al
.
 
[1
25
] 
H
ig
gi
n
s 
et
 
al
.
 
[1
28
] 
K
as
ra
i e
t a
l. 
[1
73
] 
K
lo
s 
et
 
al
.
 
[1
81
] 
La
v
er
y 
et
 
al
.
 
[2
14
] 
La
v
er
y 
et
 
al
.
 
[2
15
] 
Le
in
o
n
en
 
et
 
al
.
 
[2
18
] 
M
ah
ar
 
et
 
al
.
 
[2
26
] 
2 - Review of the literature 
 
31 
Pa
ra
m
et
er
s 
St
iff
 
St
iff
,
 
pe
ak
 
(yi
el
d) 
lo
ad
,
 
fa
ilu
re
 
m
o
de
 
R
ig
id
ity
,
 
be
n
di
n
g 
st
re
n
gt
h 
St
iff
 
M
ax
 
lo
ad
 
an
d 
di
sp
, 
st
iff
 
St
iff
 
St
iff
,
 
fa
ilu
re
 
lo
ad
 
M
ax
 
pu
llo
u
t 
fo
rc
e 
Lo
a
di
n
g 
pr
o
to
co
l 
Co
n
st
 
sp
ee
d 
(up
 
to
 
2 
m
m
 
o
r 
50
 
N
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
D
isp
 
co
n
tr
o
l 
Co
n
st
 
sp
ee
d 
Co
n
st
 
sp
ee
d 
Co
n
st
 
sp
ee
d 
 
(up
 
to
 
20
 
N
, 
0.
1 
N
m
 
o
r 
u
n
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Te
st
in
g 
m
et
ho
d 
4-
p 
be
n
di
n
g 
Ca
n
t b
en
di
n
g 
3-
p 
be
n
di
n
g,
 
to
rs
io
n
 
Pr
o
x
-
di
s 
an
d 
pa
l-d
o
r 
tr
an
sla
tio
n
,
 
to
rs
io
n
 
Te
n
sil
e 
B
io
m
ec
h 
4-
p 
be
n
di
n
g 
4-
p 
ap
ex
 
pa
lm
ar
 
be
n
di
n
g,
 
ax
ia
l 
co
m
p,
 
to
rs
io
n
 
Pu
llo
u
t 
T
yp
e 
o
f 
lo
a
di
n
g 
St
at
ic
 
St
at
ic
 
St
at
ic
 
Cy
cl
ic
 
(10
 
cy
cl
es
) 
St
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
T
es
tin
g 
co
n
di
tio
n
s 
R
T,
 
dr
y 
R
T,
 
dr
y 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
,
 
sp
ec
im
en
s 
ke
pt
 
m
o
ist
 
35
 
°
C 
0.
9 
%
 
sa
lin
e 
so
lu
tio
n
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
4 
w
ks
 
(i.
e.
,
 
28
 
d) 
at
 
37
 
°
C 
PB
S,
 
pH
 
7.
4 
12
 
d 
at
 
47
 
°
C 
PB
S 
(i.
e.
, 
40
 
d 
at
 
37
 
°
C)
,
 
pH
 
7.
4 
–
 
–
 
–
 
–
 
–
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
H
u
m
an
 
ca
da
v
er
 
bo
n
es
 
PU
 
fo
am
 
(0.
48
 
g/
cm
3 ) 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
R
ed
 
o
ak
 
w
o
o
d 
PU
 
fo
am
 
(0.
48
 
g/
cm
3 ) 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
B
o
v
in
e 
bo
n
e 
M
o
de
l 
H
an
d 
fra
ct
u
re
 
H
am
m
er
 
to
e 
co
rr
ec
tio
n
 
H
an
d 
fra
ct
u
re
 
H
an
d 
fra
ct
u
re
 
M
an
di
bu
la
r 
fra
ct
u
re
 
R
ad
iu
s 
fra
ct
u
re
 
H
an
d 
fra
ct
u
re
 
Im
pl
an
t 
fix
at
io
n
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
K
-
w
ire
 
K
-
w
ire
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
K
-
w
ire
 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
K
-
w
ire
 
K
-
w
ire
 
Im
pl
a
n
t 
PG
A
 
ro
d 
PL
G
A
 
ha
m
m
er
 
to
e 
fix
at
io
n
 
im
pl
an
t 
PL
G
A
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PD
S 
pi
n
 
PL
D
LA
/P
G
A
 
pl
at
es
 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
D
LA
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
D
LA
 
pi
n
 
PL
LA
 
pi
n
 
Ta
bl
e 
2 
-
 
co
n
t’
d.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
M
ar
u
ya
m
a 
et
 
al
.
 
[23
2]
 
Pi
et
rz
ak
 
et
 
al
.
 
[28
0]
 
Pr
ev
el
 
et
 
al
.
 
[2
87
] 
Pu
ttl
itz
 
et
 
al
.
 
[2
90
] 
R
ic
al
de
 
et
 
al
.
 
[3
01
] 
R
ik
li 
et
 
al
.
 
[3
02
] 
R
o
u
re
 
et
 
al
.
 
[3
07
] 
R
u
be
l e
t a
l. 
[3
08
] 
2 - Review of the literature 
 
 
32 
Pa
ra
m
et
er
s 
St
iff
 
Cy
cl
es
 
to
 
fa
ilu
re
,
 
fa
ilu
re
 
m
o
de
 
O
st
eo
to
m
y 
di
sp
, 
fa
ilu
re
 
m
o
de
 
St
at
ic
: 
to
rq
u
e 
an
d 
ro
t a
n
gl
e 
at
 
fa
ilu
re
 
Cy
cl
ic
: 
st
iff
 
an
d 
po
ss
ib
le
 
fa
ilu
re
 
Pu
llo
u
t f
o
rc
e,
 
fa
ilu
re
 
m
o
de
 
Pu
llo
u
t f
o
rc
e,
 
fa
ilu
re
 
m
o
de
 
Pu
llo
u
t f
o
rc
e,
 
fa
ilu
re
 
m
o
de
 
R
ig
id
ity
,
 
m
ax
 
be
n
di
n
g 
m
o
m
en
t, 
fa
ilu
re
 
to
rq
u
e 
Lo
a
di
n
g 
pr
o
to
co
l 
Co
n
st
 
sp
ee
d 
D
isp
 
co
n
tr
o
l, 
ph
ys
io
lo
gi
ca
l 
D
isp
 
co
n
tr
o
l (
ro
t) 
an
d 
co
n
st
 
lo
ad
 
(co
m
p),
 
ph
ys
io
lo
gi
ca
l 
St
at
ic
: 
co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
,
 
ro
t) 
an
d 
co
n
st
 
lo
ad
 
(co
m
p) 
Cy
cl
ic
: 
lo
ad
 
co
n
tr
o
l 
(ro
t) 
an
d 
co
n
st
 
lo
ad
 
(co
m
p),
 
ph
ys
io
lo
gi
ca
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
T
es
tin
g 
m
et
ho
d 
B
io
m
ec
h 
sh
ea
r 
Fl
ex
-
ex
t a
n
d 
ra
di
o
u
ln
ar
 
de
v
ia
tio
n
 
R
o
t a
n
d 
co
m
p 
R
o
t a
n
d 
co
m
p 
Pu
llo
u
t 
Pu
llo
u
t 
Pu
llo
u
t 
3-
p 
be
n
di
n
g 
(p
al
m
ar
,
 
la
t 
an
d 
do
r 
ap
ex
), 
to
rs
io
n
 
T
yp
e 
o
f 
lo
a
di
n
g 
St
at
ic
 
Cy
cl
ic
 
(10
00
 
cy
cl
es
) 
Cy
cl
ic
 
(40
0 
cy
cl
es
) 
St
at
ic
 
an
d 
cy
cl
ic
 
(57
70
0 
cy
cl
es
) 
St
at
ic
 
St
at
ic
 
St
at
ic
 
St
at
ic
 
Te
st
in
g 
co
n
di
tio
n
s 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
37
 
°
C 
sa
lin
e 
so
lu
tio
n
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
–
 
–
 
–
 
–
 
–
 
–
 
–
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
Po
rc
in
e 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
H
u
m
an
 
ca
da
v
er
 
bo
n
e 
Po
rc
in
e 
bo
n
e 
M
o
de
l 
St
er
n
u
m
 
fra
ct
u
re
 
W
ris
t 
fra
ct
u
re
 
A
n
kl
e 
fra
ct
u
re
 
Sy
n
de
sm
o
sis
 
in
jur
y 
Im
pl
an
t 
fix
at
io
n
 
Im
pl
an
t 
fix
at
io
n
 
Im
pl
an
t 
fix
at
io
n
 
H
an
d 
fra
ct
u
re
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
M
et
al
lic
 
w
ire
 
–
 Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
he
m
ic
er
cl
ag
e 
Sc
re
w
 
–
 
–
 
–
 Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
sc
re
w
,
 
K
-
 
w
ire
 
Im
pl
a
n
t 
PL
LA
 
pi
n
 
PL
D
LA
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
 
PL
D
LA
/T
M
C 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
PL
A
 
sc
re
w
 
PL
G
A
 
ta
ck
 
PL
G
A
 
sc
re
w
s 
an
d 
ta
ck
 
PL
G
A
 
sc
re
w
 
PL
D
LA
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
PL
D
LA
 
sc
re
w
,
 
PL
LA
 
pi
n
 
 
Ta
bl
e 
2 
-
 
co
n
t’
d.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
Sa
ito
 
et
 
al
.
 
[3
10
] 
Sh
o
rt
 
et
 
al
.
 
[3
20
] 
Sjö
bl
o
m
 
et
 
al
.
 
[32
6]
 
Th
o
rd
ar
so
n
 
et
 
al
.
 
[3
46
] 
Ti
ai
n
en
 
et
 
al
.
 
[3
49
] 
Ti
ai
n
en
 
et
 
al
.
 
[3
50
] 
Ti
ai
n
en
 
et
 
al
.
 
[3
52
] 
W
ar
is 
et
 
al
.
 
[3
90
] 
2 - Review of the literature 
 
33 
Pa
ra
m
et
er
s 
M
ax
 
st
re
n
gt
h 
M
ax
 
lo
ad
 
Lo
a
di
n
g 
pr
o
to
co
l 
Co
n
st
 
sp
ee
d 
(un
til
 
fa
ilu
re
) 
Co
n
st
 
sp
ee
d 
(un
til
 
di
sp
 
o
f 3
 
m
m
) 
T
es
tin
g 
m
et
ho
d 
4-
p 
be
n
di
n
g,
 
pu
llo
u
t 
3-
p 
be
n
di
n
g 
sim
u
la
tin
g 
m
as
tic
at
io
n
 
lo
ad
s 
T
yp
e 
o
f 
lo
a
di
n
g 
St
at
ic
 
St
at
ic
 
Te
st
in
g 
co
n
di
tio
n
s 
N
o
t 
m
en
tio
n
ed
 
N
o
t 
m
en
tio
n
ed
 
H
yd
ro
ly
tic
 
in
 
vi
tr
o
 
co
n
di
tio
n
s 
–
 
–
 
C
a
rr
ie
r 
m
a
te
ri
a
l 
Po
rc
in
e 
bo
n
e 
O
v
in
e 
bo
n
e 
M
o
de
l 
R
ib
 
fra
ct
u
re
 
M
an
di
bu
la
r 
fra
ct
u
re
 
C
o
n
tr
o
l 
im
pl
a
n
t 
(m
et
a
lli
c) 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s 
Pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
sc
re
w
 
Im
pl
a
n
t 
PL
LA
 
pl
at
e 
se
cu
re
d 
w
ith
 
sc
re
w
s,
 
PL
LA
 
sc
re
w
 
Sc
re
w
 
(m
at
er
ia
l n
o
t 
m
en
tio
n
ed
) 
 Ta
bl
e 
2 
-
 
co
n
t’
d.
 
O
v
er
v
ie
w
 
o
f s
tu
dy
 
de
sig
n
s 
o
f p
re
v
io
u
s 
bi
o
m
ec
ha
n
ic
a
l i
n
 
vi
tr
o
 
st
u
di
es
 
w
ith
 
bi
o
de
gr
a
da
bl
e 
bo
n
e 
fix
a
tio
n
 
im
pl
a
n
ts
.
 
St
u
dy
 
W
itt
en
be
rg
 
et
 
al
.
 
[3
99
] 
Öz
de
n
 
et
 
al
.
 
[4
08
] 
Ta
bl
e 
sp
ec
ifi
c 
ab
br
ev
ia
tio
n
s:
 
an
t-
po
st
 
=
 
an
te
rio
r-
po
st
er
io
r,
 
bi
o
m
ec
h 
=
 
bi
o
m
ec
ha
n
ic
al
,
 
ca
n
t =
 
ca
n
til
ev
er
,
 
co
m
p 
=
 
co
m
pr
es
sio
n
, 
co
n
st
 
=
 
co
n
st
an
t, 
d 
=
 
da
y,
 
di
sp
 
=
 
di
sp
la
ce
m
en
t, 
do
r 
=
 
do
rs
al
, 
fle
x
-
ex
t =
 
fle
x
io
n
-
ex
te
n
sio
n
,
 
in
f-s
u
p 
=
 
in
fe
rio
r-
su
pe
rio
r,
 
K
-
w
ire
 
=
 
K
irs
ch
n
er
 
w
ire
,
 
la
t =
 
la
te
ra
l, 
m
ax
 
=
 
m
ax
im
u
m
,
 
m
ed
la
t =
 
m
ed
io
la
te
ra
l, 
pa
l-d
o
r 
=
 
pa
lm
ar
-
do
rs
al
,
 
pr
o
x
-
di
s 
=
 
pr
o
x
im
al
-
di
st
al
,
 
ro
t =
 
ro
ta
tio
n
, 
st
iff
 
=
 
st
iff
n
es
s,
 
w
k 
=
 
w
ee
k,
 
3-
p 
=
 
3-
po
in
t, 
4-
p 
=
 
4-
po
in
t 
2 - Review of the literature 
 
34 
2.3.2 Preclinical in vivo testing 
 
Preclinical in vivo testing has been extensively used to study biocompatibility, degradation 
behavior, and mechanical and biomechanical properties of biodegradable implants. In preclinical 
in vivo studies, investigational devices have been implanted in test animals (e.g. rat, rabbit, sheep, 
goat, pig or dog), thereafter the animals are followed to investigate the desired parameters and to 
monitor tissue healing. The selection of the animal model may depend on what property is being 
investigated (biocompatibility, degradation, or mechanical or biomechanical properties) and the 
desired level of clinical relevance e.g. in terms of anatomy and physiology. Preclinical in vivo 
testing typically includes a combination of the following evaluation methods: clinical examination, 
imaging (radiological, ultrasound, MRI, CT), macroscopic and histological evaluation, as well as 
the determination of the mechanical, biomechanical and material properties (e.g. inherent 
viscosity, mass loss, thermal properties) [15-16, 18, 24, 34, 37-38, 57, 65, 77, 98, 112-113, 152, 
154, 167, 184-185, 187, 195, 197, 221, 223, 227, 229-230, 234, 236, 241-242, 246, 251, 256-258, 
263, 270, 283, 285-286, 289, 291, 296, 309, 312, 321, 337-340, 342, 351, 353-355, 361, 366, 372-
373, 375-378, 389, 397, 403]. 
 
The biocompatibility of the biodegradable materials currently in clinical use is well-known and has 
been widely reported in the literature [9, 53, 58, 146, 245, 336]. Therefore new preclinical in vivo 
studies are not always needed when these materials are used in creating new implants. However, 
the biocompatibility of any new implants containing some novel, previously not studied 
biodegradable materials, should always be tested preclinically. Currently preclinical 
biocompatibility testing can only be carried out by using in vivo methods. Even after the 
preclinical in vivo testing, the biocompatibility always needs to be confirmed in humans due to 
potential effect of differences between species (e.g. in local vascularity, metabolism, body 
temperature etc.). For example, typically the likelihood of postoperative material degradation 
related tissue reactions is lower in animals than in humans and there are cases where a 
biodegradable implant has shown good biocompatibility results preclinically [383] but the clinical 
outcome has been unsatisfactory [85]. 
 
In hydrolytic in vitro testing, the degradation of the biodegradable implants occurs due to pure 
hydrolysis and the clearance effect of local vascularity and cells (mainly macrophages) is excluded 
[257]. Accordingly, complete elimination of the implant material cannot be achieved in an in vitro 
model because last phase debris cannot be fully cleared as will occur in vivo [227, 369, 372]. In 
preclinical in vivo testing, all of the above mentioned elements are present and this has been 
advocated [227, 369, 372] as the reason why in some studies there is faster degradation observed 
in vivo than in vitro [65, 321, 336, 339, 372-373]. Also the contribution of enzymatic hydrolysis to 
account for the more rapid degradation often seen in preclinical animal models in comparison to in 
vitro models has been discussed [227, 336, 369, 372]. However, in some studies, the hydrolytic 
degradation results obtained in vitro have been almost identical with preclinical in vivo 
degradation results [227, 236, 257, 342]. For example, Nieminen et al. (2008) have shown that the 
hydrolytic in vitro behavior of co-polymer material containing PLDLA and TMC (i.e., a material 
identical to that used to make the implants investigated in this thesis) is almost identical to that 
determined in vivo in sheep [257]. Nieminen et al. reported that the material becomes soft within 
6-12 months and degrades completely within 24 months without any harmful inflammatory or 
foreign body reactions. Correspondingly in another preclinical in vivo study utilizing a rabbit 
model, only minimal amounts of similar implant material remained at 18 months after 
implantation [223]. 
 
In addition to the effect of local vascularity and cells, also temperature has been shown to have a 
significant effect on the rate of material degradation (i.e., higher temperature leading to faster 
degradation) [3, 72, 279-280]. In this context, it should be noted that the body temperature of the 
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commonly used test animals is higher than that of humans [107, 279, 396] and this cannot be 
controlled as in the way it can under in vitro conditions.  
 
Some preclinical in vivo studies have examined the changes occurring over time in the strength 
and fixation properties of biodegradable bone fixation implants (after sacrifice of the test animals). 
The testing has been conducted either after implant explantation (i.e., mechanical property testing) 
[16, 112, 154, 185, 197, 227, 229, 236, 257, 286, 291, 342, 361, 372-373, 397] or after the implant 
has been removed together with the adjoining tissues which permits testing of whole, intact 
implant-bone specimens (i.e., biomechanical testing) [15-16, 18, 152, 154, 221, 230, 270, 337-
338]. However, the physiological loading conditions (frequency, amplitude, direction etc.) in 
preclinical animal models rarely adequately reflect the situation in human patients. This is not only 
due to clear anatomical differences between species (e.g. size and shape of bones and other 
structures, posture, weight, bone density etc.) [65, 227, 236, 262, 279, 303, 305, 321, 369, 372-
373], but also due to lack of controlled postoperative behavior, Typically, restricted weight bearing 
or even immobilization is necessary after treatment with biodegradable bone fixation implants [4, 
6, 43, 92, 134, 151, 153, 157, 159, 175, 191, 246, 252, 273-274, 323-324, 346, 380] but are rarely 
included in any of the animal models. In contrast to the situation with preclinical in vivo testing, in 
in vitro testing all of the loading parameters can be selected and controlled as desired.  
 
 
2.3.3 Clinical testing 
 
Although the above discussed in vitro and preclinical in vivo testing are valuable product 
development tools, and critically important parts of the evaluation of the adequacy of new 
biodegradable bone fixation implants, and usually necessary before those can be implanted into 
human patients, the definitive safety and efficacy of the implants can only be verified by 
conducting appropriate clinical studies. When the clinical adequacy of biodegradable implants is 
being investigated, optimally the follow-up time should be at least as long as the expected 
degradation time of the implants. 
 
The clinical suitability of various biodegradable plates and screws for fixation of bone fragments 
in cranio-maxillofacial (CMF) surgery has been extensively investigated and the majority of the 
existing clinical data provide support for the evidence that biodegradable implants in CMF 
applications are both safe and efficacious [5, 19, 23, 32-33, 35, 49, 60, 67-68, 74-76, 87-91, 94-95, 
97-99, 103-104, 112, 122-124, 132, 138, 164-166, 178, 193-194, 199, 201, 205-209, 213, 219, 
224, 228, 233, 239, 259, 269, 271, 277, 316-318, 336, 341, 343, 356-357, 394, 397, 400, 404-407]. 
However, only a few prospective randomized CMF related studies have been published so far [67-
68, 259] and in many of the published clinical studies, the follow-up time has been shorter (on 
average equal to or less than 12 months) than the actual or expected degradation time of the 
implants studied [5, 35, 49, 60, 67-68, 74-75, 87-89, 91, 98, 103-104, 112, 123-124, 164, 178, 193-
194, 207-209, 213, 219, 228, 233, 239, 259, 269, 277, 318, 343, 394, 400, 404, 407]. Although one 
year follow-up may be sufficient from the bone healing point of view, it rarely is long enough 
from the biocompatibility point of view, since it is known that adverse degradation related tissue 
reactions can occur even several years later i.e., when the material finally degrades [33, 53, 58, 
200, 381]. In this context, it should be noted that complete degradation time is strongly material 
dependent and therefore the follow-up time should always be set based on the expected complete 
degradation time of the implant under investigation. 
 
Biodegradable rods, pins and screws have also been successfully used for other orthopaedic bone 
fixation applications (e.g. fractures of the foot, ankle, hand, wrist, elbow etc.) [4, 6, 9, 20-21, 28-
30, 39, 42-43, 47-48, 50-51, 53-55, 58, 61, 66, 82-83, 109, 111, 114-115, 119, 127, 129, 131, 133-
134, 144-145, 147-148, 151, 153, 156-159, 169, 171-172, 175, 183, 186, 190, 196-198, 216, 231, 
235, 237, 252, 254-255, 267, 273-276, 284, 288, 293, 298, 304-305, 323-325, 328, 332, 345, 347-
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348, 368, 374, 378, 380-382, 388, 398, 402] but data from prospective randomized trials is limited 
[43, 54, 61, 66, 83, 148, 158, 171-172, 175, 197, 288, 298, 304, 332, 348, 374] and once again, in 
several studies the follow-up times have been short (on average equal to or less than 12 months) in 
view of the time of complete degradation [4, 21, 30, 42, 51, 111, 114, 127, 148, 151, 157, 171-172, 
196-198, 288, 323, 328, 348, 378]. Furthermore, only a limited amount of published data is 
currently available on the use of biodegradable bone fixation plate-screw constructs in the fixation 
of bone fragments outside the CMF region [86, 92, 101, 110, 135, 163, 191, 238, 247, 260, 370, 
384, 388, 391]. Seven of these publications report clinical results after using plate and screws 
made out of PLDLA or PLDLA/TMC (i.e., material similar to the implants investigated in this 
thesis). In two of the papers, biodegradable PLDLA co-polymer based mesh plates and screws 
were used with good clinical results in iliac crest reconstruction after harvesting of autograft bone 
[101, 384]. Mayberry et al. (2003) reported an acceptable clinical outcome after the use of PLDLA 
plates and screws in the fixation of rib fractures [238]. In addition, Novak et al. (2006) and Waris 
et al. (2004) have successfully treated fractures of the hand with PLDLA/TMC and PLDLA mini-
plates and screws [260, 391]. Furthermore, Kainonen et al. (2008), and Kukk and Nurmi (2009) 
recently reported their encouraging clinical experience with PLDLA/TMC plate and screws in the 
treatment of lateral malleolar fractures of the ankle [163, 191]. 
 
 
2.4 Summary of the literature review 
 
Considering the scope of this thesis, the following are the most important conclusions that can be 
drawn based on the review of the previously published literature:  
 
1. In most of the previous in vitro studies with degradation period, only mechanical 
properties, not biomechanical fixation properties of biodegradable bone fixation implants 
have been investigated. Additionally, in most of the biomechanical studies examining 
biodegradable bone fixation implant constructs, static, not clinically relevant cyclic 
loading, has been used and testing has been conducted only initially under dry conditions 
and without the presence of the clinically relevant hydrolytic in vitro degradation 
conditions. In fact, before the present thesis there was no biomechanical study that 
combined all three clinically relevant factors, i.e., complete biodegradable bone fixation 
implant construct with bone fracture fixation model, indication-specific physiological 
cyclic loading and degradation period typically required for bone to heal, has not been 
conducted with biodegradable bone fixation implants before the present thesis. 
 
2. In order to achieve sufficient stability, the biodegradable plates and screws are commonly 
thicker and wider than the corresponding metal implants. The thickness of the 
biodegradable plates resulted in complaints about their bulkiness. Furthermore, these 
excessively bulky plates and the protruding screw heads of the biodegradable systems have 
been reported to increase the risk of postoperative tissue reactions. Accordingly, smaller 
and more low-profile implants and fixation implant constructs are nowadays preferred.  
 
3. It is often uncertain how strong specific bone fixation implants actually need to be to 
provide clinically sufficient stability and direct comparison of biodegradable bone fixation 
implants to corresponding or similar conventional metallic implants may not be relevant 
and probably does not provide any informative data. Accordingly, product- and indication-
specific test protocols and methods for the testing of the biodegradable bone fixation 
implants should be developed and utilized. 
 
4. There have been few biomechanical studies conducted with biodegradable PLDLA and 
PLDLA/TMC based bone fixation plate-screw constructs. Furthermore, the clinical use of 
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these implant constructs in other orthopaedic indications other than CMF applications has 
not been extensively investigated. 
 
5. PLDLA based biodegradable mesh plates and screws have been previously used 
successfully in iliac crest reconstruction after harvesting of autograft bone from the pelvis. 
However, biodegradable implants have not been previously used in the hip joint for 
converting an uncontained acetabular bone defect into a contained defect to allow bone 
impaction grafting without the use of metallic graft containment hardware. 
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3 AIMS OF THE STUDY 
 
The general hypothesis of this thesis was that: the investigated biodegradable PLDLA/TMC bone 
fixation plate-screw constructs would retain clinically sufficient fixation stability over a clinically 
relevant period of time under hydrolytic in vitro conditions; and the biodegradable PLDLA/TMC 
mesh plate and screws studied would be suitable for novel clinical applications for biodegradable 
implants. In addition, the general aim of this thesis was to develop product- and indication-specific 
static and cyclic biomechanical test methods with which to evaluate the fixation properties of the 
biodegradable bone fixation implant constructs under hydrolytic in vitro conditions. 
 
The specific aims of the present thesis were to investigate: 
 
1. whether the screw heads of biodegradable screws securing a novel biodegradable “free-
form” osteosynthesis plate can be safely removed by cutting them off after screw insertion 
to reduce the bulkiness and volume of the implant construct without compromising the 
initial and postoperative biomechanical fixation properties of the implant construct, 
 
2. whether a biodegradable ankle plate secured with biodegradable screws can be anticipated 
to withstand physiological cyclic loading and to maintain the reduction of a lateral 
malleolar fracture postoperatively until the fracture has healed, 
 
3. the effect of simulated physiological cyclic loading on the inherent viscosity 
(demonstrating hydrolytic in vitro degradation) of a biodegradable ankle plate-screw 
construct, 
 
4. the changes in inherent viscosity, mass, and strength retention properties (demonstrating 
hydrolytic in vitro degradation) of a biodegradable mesh plate and screw over time under 
hydrolytic in vitro conditions, and 
 
5. the suitability of the biodegradable mesh plate and screws for converting an uncontained 
acetabular bone defect into a contained defect to allow bone impaction grafting in selected 
osteoarthritic arthroplasty patients without the use of permanent graft containment 
hardware. 
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4 MATERIALS AND METHODS 
 
The materials and methods of the studies of this thesis are summarized in chapters 4.1-4.4. The 
following chapters also describe the product- and indication-specific biomechanical test methods 
developed and used. The present thesis consists of four studies which are referred to as I-IV in the 
text. 
 
 
4.1 Biodegradable bone fixation implants 
 
The biodegradable bone fixation implants investigated in this thesis are summarized and shown in 
Table 3 and Figure 6. All implants investigated are commercially available products manufactured 
by Inion Oy (Tampere, Finland) and have been molded from a miscible polymer blend consisting 
of poly(L-lactide-co-D,L-lactide) and poly(L-lactide-co-trimethylene carbonate) copolymers, i.e., 
PLDLA/TMC. The exact weight ratios of the copolymers varied according to the different implant 
applications. The implants are sterilized by gamma irradiation. More detailed information about 
the material composition and manufacturing processes of the implants is confidential. All samples 
of this study were from normal production batches. 
 
 
Table 3. The investigated biodegradable bone fixation implants. 
 
Implant Intended use 
Inion FreedomPlate™, i.e., free-form 
plate (I-II) 
In the presence of appropriate additional immobilization or 
fixation, intended for maintenance of alignment and fixation 
of bone fractures, osteotomies, arthrodeses or bone grafts, 
and maintenance of relative position of weak bony tissue 
(e.g. bone grafts, bone graft substitutes, or bone fragments 
from comminuted fractures), in trauma and reconstructive 
procedures. 
Inion CPS®/OTPS™ extended 4-hole 
plate, i.e., 4-hole plate (I) 
Intended for use in trauma and reconstructive procedures in 
the craniofacial skeleton, mid-face, maxilla, and mandible 
(in conjunction with appropriate maxillomandibular 
fixation), and in the fixation of non-comminuted diaphyseal 
metacarpal, proximal phalangeal and middle phalangeal 
fractures and osteotomies in the presence of appropriate 
immobilization. 
Inion OTPS™ 8-hole ankle plate, i.e., 
ankle plate (III) 
Intended for maintenance of reduction and fixation of 
cancellous bone fractures, osteotomies or arthrodeses of the 
upper extremity, ankle and foot in the presence of 
appropriate plaster cast immobilization. 
Inion OTPS™ mesh plate, i.e., mesh plate 
(IV) 
Intended to sustain the relative position of weak bony tissue 
or bone fragments from comminuted fractures, and for 
cement restriction in total joint arthroplasty procedures. 
Inion® screws with diameter of 2.0 mm 
(I-II), 2.8 mm (III) and 3.1 mm (IV) 
Intended for the fixation of the biodegradable plates 
mentioned above. 
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Figure 6. Test sample implants from left to right: free-form plate (I-II), 4-hole plate (I), ankle plate 
(III), mesh plate (IV), and the screws with diameters of 2.0 mm (I-II), 2.8 mm (III) and 3.1 mm (IV) 
used to secure the plates. 
 
 
4.2 In vitro testing 
 
 
4.2.1 Specimen preparation for in vitro testing (I-IV) 
 
The in vitro test samples and specimens, and study groups of original publications of this thesis are 
summarized in Figures 7-8. The preparation and fixation of the implants with carrier materials, i.e., 
acrylic tubes (Vink Finland Oy, Tampere, Finland), PU foam blocks with density of 0.48 g/cm3 
(i.e., 30 pcf) (Sawbones Europe AB, Malmö, Sweden) or PE rods (Vink Finland Oy), were carried 
out with product-specific instruments (Inion Oy) and according to the instructions for use provided 
by the manufacturer. The carrier materials used have been previously recommended for and used 
in biomechanical testing of bone fixation implants [10-11, 13, 25, 40, 100, 116, 143, 188, 280, 
302]. After preparing appropriate bone simulating carrier material specimens, the plates were 
immersed in a warm water bath (55 °C for 4-hole plate and 70 °C for all other plates) for one 
minute, thereafter they were contoured to match the contours of the carrier material, then the screw 
holes were drilled and tapped into the carrier material through the holes in the plates, and finally 
the plates were secured to the carrier material with the applicable screws (Fig. 6-10, Table 3, I-III). 
The free-form plates were additionally cut to the size of specific test samples directly after the 
water bath treatment prior to contouring and fixation (Fig. 9a-b, I-II). In addition, the mesh plates 
were cut to the size of specific test samples directly after the water bath treatment (IV). 
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Study I 
Study II 
Figure 7. The in vitro test samples and specimens, and study groups (I-II). 
Group 2 
30 pc free-form plates 
fixed with screws with 
cut-off screw heads 
Hydrolytic in vitro degradation 
of 0 (i.e., 24 hours), 6, 9, 12, 20 and 26 weeks 
Group 2 
30 pc free-form plates  
fixed with screw with 
cut-off screw head 
Samples and carrier materials 
120 pc free-form plates 
300 pc 2.0 mm screws 
120 pc acrylic tubes 
60 pc PU foam blocks 
 
Specimens 
60 pc free-form plates (cut to size of 28 x 7 mm), 
each fixed with 4 screws to 2 acrylic tubes 
 
Group 1 
30 pc free-form plates 
fixed with 
countersunk screw  
Group 1 
30 pc free-form plates 
fixed with 
countersunk screws 
Plate-screw construct tensile test 
(n=5 for each time point) 
 
Plate-screw construct pullout test 
(n=5 for each time point) 
Specimens 
60 pc free-form plates (cut to size of 20 x 20 mm), 
each fixed with 1 screw to PU foam block  
 
Hydrolytic in vitro degradation of 24 hours 
Plate-screw construct 
cantilever bending test (n=4) 
Plate-screw construct 
tensile test (n=4) 
 
Group 1 
8 pc free-form plates, each fixed 
with 4 countersunk screws 
to 2 acrylic tubes 
Group 3 
8 pc 4-hole plates, each fixed 
with 4 screws 
to 2 acrylic tubes 
Group 2 
8 pc free-form plates, each fixed 
with 4 screws with cut-off screw heads 
to 2 acrylic tubes 
Samples and carrier material 
16 pc free-form plates (cut to size of the 4-hole plate) 
8 pc 4-hole plates 
96 pc 2.0 mm screws 
48 pc acrylic tubes 
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Study III 
Study IV 
Figure 8. The in vitro test samples and specimens, and study groups (III-IV). 
Inherent viscosity determination 
Hydrolytic in vitro 
degradation of 24 hours 
Hydrolytic in vitro degradation of 12 weeks 
Group 1 
Four phased cyclic loading (n=5) 
Group 2 
Single phase cyclic loading (n=3) 
Group 3 
No cyclic loading (n=3) 
Initial inherent viscosity 
determination (n=3) 
Samples and carrier material 
14 pc ankle plates 
112 pc 2.8 mm screws 
28 pc PE rods 
Specimens 
Each ankle plate fixed with 8 
screws to 2 PE rods 
Samples 
110 pc mesh plates 
110 pc 3.1 mm screws 
Hydrolytic in vitro degradation of 0 (i.e., 24 hours), 4, 8, 12, 16, 20, 26, 40, 52 and 104 weeks 
 
 
 
 
Mass loss determination 
(n=3 for each time point) 
Inherent viscosity determination 
(n=3 for each time point) 
Mechanical property test 
(n=5 for each time point) 
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Figure 9. The test specimens for the biomechanical testing examined in this thesis: a) the free-form 
plate test specimens with into-the-plate countersunk screws (on the top) and with cut-off screw heads 
(in the middle) and 4-hole plate test specimen (on the bottom) for the plate-screw construct tensile test 
(chapter 4.2.3.1.1, I-II) and plate-screw construct cantilever bending test (chapter 4.2.3.1.2, I); b) the 
free-form plate test specimens with into-the-plate countersunk screws (on the left) and with cut-off 
screw heads (on the right) for the plate-screw construct pullout test (chapter 4.2.3.1.3, II); and c) the 
ankle plate test specimen for the cyclic biomechanical test (chapter 4.2.3.2, III). 
 
 
 
 
Figure 10. Schematic drawing of the free-form plate (I-II) to illustrate: a) an into-the-plate countersunk 
screw; and b) a screw with a cut-off screw head. 
 
 
4.2.2 Hydrolytic in vitro conditions 
 
Hydrolytic in vitro conditions for the test specimens (I-IV) were created according to the 
guidelines of the existing material test standards for biodegradable polymer materials [140-141]. 
Accordingly, after the preparation of the test specimens, the specimens and samples for 
a  b 
c 
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mechanical, biomechanical and material property tests were placed in individual containers filled 
with PBS (pH 7.4±0.2) and incubated at 37±1 °C until testing which was conducted at certain time 
points during the hydrolytic in vitro period. The 0-week tests were conducted after 24 hours’ 
incubation to ensure relaxation of the biodegradable implants at body temperature [45-46] and 
water absorption prior to testing. The incubation PBS was changed and pH measured biweekly. 
 
 
4.2.3 Biomechanical and mechanical property testing 
 
The static biomechanical (I-II) and mechanical property tests (IV) were conducted by using Zwick 
Z020/TH2A universal materials testing machine (Zwick GmbH, Ulm, Germany) and cyclic 
biomechanical tests (III) with the Instron 8874 servo hydraulic testing machine (Instron Co, 
Canton, MA, USA). Zwick is a uniaxial test machine for tension-compression testing and the 
Instron multiaxial machine is capable of undertaking combined tension-compression and rotation 
movements. All static tests were carried out in water at 37±1 °C and cyclic tests in ionized water at 
37±1 °C respectively. In all tests, the test specimens were rigidly fixed to the test machine with 
specially designed metallic testing fixtures. The testing quantities were automatically obtained and 
recorded. 
 
 
4.2.3.1 Static biomechanical testing 
 
Static biomechanical tests developed included plate-screw construct tensile (I-II), cantilever 
bending and (I) pullout tests (II) for free-form plate and 4-hole plate specimens (Fig. 7 and 9a-b). 
In all static biomechanical tests, yield load and yield bending moment values were determined as 
the first point on the load-displacement curves at which the increase in displacement occurred 
without any increase in load [14]. Similarly, initial stiffness values were determined as the slope of 
the initial linear region of load-displacement curves corresponding to the steepest straight-line 
tangent to the curves [59, 136, 261]. 
 
 
4.2.3.1.1 Plate-screw construct tensile test (I-II) 
 
In the plate-screw construct tensile test, the test specimen (Fig. 9a) was loaded in a direction 
parallel to the long axis of the acrylic tube at a constant speed of 5 mm/min until failure of fixation 
(Figure 3 of the original publication I). Figure 11 is a simplified illustration showing the direction 
of loading in the plate-screw construct tensile test. The yield load (N), maximum load (N) and 
initial stiffness (N/mm) were recorded, and the failure mode was visually determined. 
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Figure 11. Schematic illustration of loading direction in the plate-screw construct tensile test (I-II): a) 
an into-the-plate countersunk screw; and b) a screw with a cut-off screw head. 
 
 
4.2.3.1.2 Plate-screw construct cantilever bending test (I) 
 
In the plate-screw construct cantilever bending test, one end of the acrylic tube of the test 
specimen (Fig. 9a) was rigidly fixed and the specimen was loaded (bent upwards) from the other 
end of the tube (length of the moment arm was 45 mm) at a constant speed of 50 mm/min until 
failure of fixation (Figure 4 of the original publication I). Figure 12 is a simplified illustration 
showing the direction of loading in the plate-screw construct cantilever bending test. The yield 
bending moment (Nmm) and initial stiffness (N/mm) were recorded, and the failure mode was 
visually determined.  
 
 
 
 
Figure 12. Schematic illustration of loading direction in the plate-screw construct cantilever bending 
test (I): a) an into-the-plate countersunk screw; and b) a screw with a cut-off screw head. 
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4.2.3.1.3 Plate-screw construct pullout test (II) 
 
In the plate-screw construct pullout test, the test specimen (Fig. 9b) was loaded in a direction 
parallel to the long axis of the screw at a constant speed of 5 mm/min until failure of fixation 
(Figure 5 of the original publication II). Figure 13 is a simplified illustration showing the direction 
of loading in the plate-screw construct pullout test. The yield load (N), maximum load (N) and 
initial stiffness (N/mm) were recorded, and the mode of failure was visually determined. 
 
 
 
 
 
   
 
Figure 13. Schematic illustration of loading direction in the plate-screw construct pullout test (II): a) an 
into-the-plate countersunk screw; and b) a screw with a cut-off screw head. 
 
 
4.2.3.2 Cyclic biomechanical testing (III) 
 
Cyclic biomechanical testing was conducted for ankle plate specimens (Fig. 8, 9c and 14). 
Identical specimens of Group 1 and 2 were loaded during 12 weeks in hydrolytic in vitro 
conditions according to the cyclic loading protocols developed and described in Table 4. In Group 
1, the number of loading cycles and the frequency of loading were gradually increased to 
correspond to the anticipated gradual increase in walking distance and walking speed during the 
postoperative healing period. During cyclic loading phases, each test specimen was loaded with 
vertical cyclic compression loading (maximum of 100 N and minimum of 10 N) and with rotation 
of 2° (clockwise) around the long axis of the plate. The direction of the vertical load was parallel 
to the long axis of the plate and perpendicular to the long axis of the screws (Fig. 14). The shape of 
the loading cycle for both loading axes was sinusoidal. In order to evaluate fixation stability, 
displacements and torque values were determined and recorded in the vertical and torsion 
directions respectively. In Group 2, a single cyclic loading phase of 36000 loading cycles 
(corresponding to the total number of loading cycles in Group 1) at a frequency of 1 Hz 
(corresponding to the highest frequency used in Group 1) was conducted after 12 weeks in 
hydrolytic in vitro conditions. 
 
 
a b 
4 - Materials and methods 
 
 
49 
Table 4. Cyclic loading protocols (III). 
 
Hydrolytic in vitro 
time (weeks)a 
Number of 
loading cyclesb 
Cyclic compression 
load, min-max (N)c 
Frequency 
(Hz)d 
Cyclic rotation 
movement (°)e 
Group 1 
2 1000 10-100 0.5 0-2 
5 5000 10-100 0.5 0-2 
8 10000 10-100 1.0 0-2 
12 20000 10-100 1.0 0-2 
Group 2 
2 – – – – 
5 – – – – 
8 – – – – 
12 36000 10-100 1.0 0-2 
aCorresponding to a typical protocol for postoperative care, i.e., gradual increase in weight bearing. 
bCorresponding to expected gradual increase in walking distance over time (1000 cycles estimated to 
correspond to approximately 1 km of walking with average step length of 50 cm). 
cCorresponding to load borne by the fibula during normal weight bearing, i.e., less than 10 % of body weight 
[401] of a person weighing approximately 100 kg. 
dCorresponding to the expected gradual increase in walking speed over time. 
eCorresponding to normal 2° external rotation of distal fibula during dorsiflexion of the ankle during normal 
weight bearing [244, 344]. 
 
 
   
 
Figure 14. The schematic drawing of the test set-up for the cyclic biomechanical test (III) on the left 
and the specimen fixed with servo hydraulic testing machine on the right. Note that the actual cyclic 
testing was performed in ionized water at 37 °C. 
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4.2.3.3 Static mechanical property testing (IV) 
 
Mechanical properties of the mesh plates and 3.1 mm screws were determined by static shear tests. 
In the shear tests, the samples were loaded in product specific metallic shear test fixtures at a 
constant speed of 5 mm/min until breakage of the sample (Fig. 15). The maximum shear strengths 
(MPa) were determined. 
 
 
  
 
Figure 15. The schematic drawing of the shear test set-up for the mesh plate and screw on the left and 
the actual test set-up on the right (IV). Note that the actual mechanical testing was performed in water 
at 37 °C. 
 
 
4.2.4 Inherent viscosity and mass loss determination 
 
Inherent viscosity and mass loss determination measurements were performed following the 
guidelines of the existing material test standards for biodegradable polymer materials [12, 140-
141]. 
 
 
4.2.4.1 Inherent viscosity (III-IV) 
 
Reduction in inherent viscosity of a biodegradable polymer material represents reduction of its 
molecular weight, which occurs as the polymer degrades. The molecular weight represents an 
average polymer chain length. The inherent viscosities (dl/g) of the samples were characterized by 
capillary viscometer (Schott Ubbelohde; Schott Instruments GmbH, Mainz, Germany). The flow-
time of diluted samples was compared to the flow-time of pure chloroform. The samples were 
prepared by dissolving 20.0±0.4 mg of the samples into 20±0.1 ml of chloroform. The 
measurements were performed at 25±1 ºC.   
 
 
4.2.4.2 Mass loss (IV) 
 
Mass loss of the biodegradable polymer implants occurs after the loss of mechanical properties. 
The mass loss represents absorption of the polymer. The mass (mg) of the samples was measured 
Test sample 
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by Mettler Toledo AX205 DeltaRange® balance (Mettler Toledo Inc, Columbus, OH, USA). Prior 
to mass loss determination, the samples were extracted from the containers and dried in a vacuum 
for four days. Thereafter they were weighed and mass loss (%) was determined by comparing the 
remaining mass to the initial mass determined prior to incubation in the hydrolytic in vitro 
conditions. 
 
 
4.3 Clinical testing (IV) 
 
In the clinical pilot study, the suitability of the biodegradable mesh plate secured with 
biodegradable screws for converting an uncontained acetabular bone defect (in the hip joint) into a 
contained defect to allow bone impaction grafting in selected osteoarthritic arthroplasty patients 
without the use of permanent graft containment hardware was investigated for the first time. The 
ethical committee of the Pirkanmaa Hospital District approved the protocol of the pilot study 
(R03080) and the patients signed informed consent forms before participation in the study. All 
operations were performed by the same surgeon in Coxa Oy, Hospital for Joint Replacements 
(Tampere, Finland).  
 
 
4.3.1 Patients 
 
The patient demographics are shown in Table 5. The mean age of the patients was 61 years (range 
46-69 years) at the time of the operation. The patients were selected so that filling of the bone 
defect was not critical for the implant stability (and based on the hydrolytic in vitro results, the 
mesh plate was not expected to lose its strength before implant stability acquisition), and thus the 
outcome of the operation was not jeopardized. These patients had either mild dysplastic primary 
acetabulum or an acetabular defect associated with cup revision, where defect treatment was not 
crucial in the implant stability. Treatment of the defect, however, supported the bone-stock 
restoring approach. The detailed inclusion and exclusion criteria are described in the manuscript 
(Table 1) of the original publication IV. 
 
 
Table 5. Patient demographics (IV). 
 
Patient 
number 
Age 
(years) 
Charnley 
classa 
Acetabular 
defectb 
Arthroplasty 
operation 
Graft 
type 
1 46 A Dysplastic 
cranial defect Primary Autograft 
2 56 B Dysplastic 
cranial defect Primary Autograft 
3 64 A Type IIC Revision Allograft 
4 69 A Type IIA Revision Allograft 
5 67 B Type IIC Revision Allograft 
6 65 C Type IIC Revision Allograft 
aA) Unilateral hip disease with no other disability; B) bilateral hip disease with no other disability; and C) 
unilateral or bilateral hip disease with generalized systemic factor affecting function [64]. 
bClassified according to Paprosky classification system [264]. 
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4.3.2 Surgical protocol  
 
The operations were performed with the patient in the lateral decubitus position and using a 
posterolateral approach. The mesh plate was used to convert the uncontained acetabular defect, 
located either peripherally at the rim or at floor of the acetabulum, into a contained defect. Prior to 
fixation, the mesh plate was cut to a suitable size and then placed in the warm water bath (70 °C) 
to make it temporarily malleable to enable contouring according to the contours of the defect (Fig. 
16). The shaped mesh plate was fixed in place with the 3.1 mm screws. The acetabulum which had 
thus been converted into a contained defect was consequently packed with autograft or allograft 
bone chips (including the area containing the mesh plate) to restore the bone stock as well as 
possible. In all cases, an uncemented porous coated acetabular cup was then implanted by 
conventional methods of revision surgery. 
 
 
 
 
Figure 16. Implantation of the mesh plate into the rim of the acetabulum (IV): a) manual contouring of 
the mesh plate according to the contours of the defect; and b) fixation of the mesh plate into its final 
position with screws. 
 
 
4.3.3 Follow-up protocol 
 
On the first postoperative day the patients started with the rehabilitation program under the 
supervision of a physiotherapist. The time for using crutches and degree of early postoperative 
weight bearing was determined individually according to the stability of the reconstruction. 
 
The follow-up examination regimen was the same for each subject. The follow-up points were at 
2-3 days, 2 months, 6 months and 12 months postoperatively. At each follow-up visit, hip joint 
radiographs were taken and an independent medically qualified person and the physiotherapist 
evaluated and scored the patients according to the Harris Hip Score (HHS) evaluation method 
[126]. The first radiographs were taken in antero-posterior and lateral (lateral with horizontal 
beam, Sven-Johannson´s) views, and the following radiographs in antero-posterior and medio-
lateral (Lauenstein´s) views respectively. The radiographs were taken with Siemens AXIOM 
Aristos FX Plus (Siemens AG, Erlangen, Germany) or Philips Digital Diagnost (Philips 
Electronics N.V., Eindhoven, the Netherlands) machines. Each patient’s hip joint radiographs were 
interpreted in a consensus meeting of a musculoskeletal radiologist and an orthopedic surgeon, 
who were blind to the other clinical data of the patients. All measurements were taken with the 
Agfa Impax DS3000 workstation (Agfa-Gevaert N.V., Mortsel, Belgium). The stability of the 
implant and incorporation of bone grafts as well as any complications were recorded.  
 
a  b 
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One year after the operation, the patients took part in the contemporary follow-up regimen of hip 
arthroplasty patients carried out by the Coxa Oy, Hospital for Joint Replacements. The radiograph 
and HHS giving the longest follow-up were used for the final examination. 
 
 
4.4 Statistical analyses 
 
The results of the test quantities were reported as mean and standard deviation (SD). In addition, in 
the original publication I, the 95 % confidence intervals (CI) were calculated and presented. 
Furthermore, for this thesis, complementary 95 % CI values were calculated also for the test 
quantities of the original publications II and III. The changes in test quantities over time during 
incubation under hydrolytic in vitro conditions were reported as relative changes (%) in 
comparison to the initial values (IV). In statistical calculations of the Group 1 in cyclic 
biomechanical test (III), the eventual values of the parameters at the end of each test phase were 
compared. Results from tests with different in vitro incubation times were considered to be 
independent. Thus, one-way ANOVA with Dunnett's T3 post hoc test was used in the calculations. 
Accordingly, for the inherent viscosities of Groups 1, 2 and 3, one-way ANOVA with Dunnett's 
T3 post hoc test was used. The difference between groups (test quantities and inherent viscosity 
measurements) in each test (I-III) was determined by using a paired Student t-test. A P-value less 
than 0.05 was considered statistically significant. 
4 - Materials and methods 
 
 
54 
 
  
 
55 
5 RESULTS  
 
The main results of this thesis are summarized in Tables 6-7 and Figures 17-29. All developed 
product- and indication-specific test methods were successfully used in the testing of this thesis. 
The original publications of this thesis are referred to as I-IV in the text. 
 
 
5.1 Biomechanical fixation properties of the free-form plate secured with 
screws with cut-off screw heads (I-II) 
 
Table 6 shows the failure modes of the free-form plate and 4-hole plate specimens in plate-screw 
construct tensile, cantilever bending and pullout tests. 
 
 
Table 6. Failure modes of the specimens (I-II). “n” indicates the number of failures. 
 
 Static biomechanical test 
Group Plate-screw construct tensile test (I-II) 
Plate-screw construct 
cantilever bending test (I) 
Plate-screw construct pullout 
test (II) 
1 Screw shaft breakage (n=29) 
* 
 
Plate bending (n=4) Screw shaft breakage (n=24) 
Screw pullout from the PU foam 
after six weeks under hydrolytic 
in vitro conditions (n=1) 
* 
2 Screw shaft breakage (n=29) 
* 
Plate bending (n=4) Screw shaft breakage (n=25) 
* 
3 Plate breakage (n=3) 
Screw shaft breakage (n=1) 
Plate bending (n=4) N/A 
*Samples had lost their mechanical strength after 26 weeks under hydrolytic in vitro conditions and could not 
be tested (n=5). 
 
 
5.1.1 Plate-screw construct tensile test (I-II) 
 
The initial stiffness (Fig. 19) of the free-form plate specimens with countersunk screws (Group 1) 
was found to be significantly higher than that of the 4-hole plate specimens (Group 3) in the plate-
screw tensile test (I). No significant differences were found between the groups (I-II) in any other 
parameters at any time point (Fig. 17-20). 
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Figure 17. Yield loads (mean±SD) in the plate-screw construct tensile test (Table II of the original 
publication I). 
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Figure 18. Yield loads (mean±SD) of the free-form plate specimens in the plate-screw construct tensile 
test during incubation under hydrolytic in vitro conditions for 26 weeks (Table II of the original 
publication II). 
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Figure 19. Initial stiffness values (mean±SD) in the plate-screw construct tensile test (Table II of the 
original publication I). 
*P<0.001 between Groups 1 and 3, †95 % CIs do not overlap between Groups 1 and 3 
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Figure 20. Initial stiffness values (mean±SD) of the free-form plate specimens in the plate-screw 
construct tensile test during incubation under hydrolytic in vitro conditions for 26 weeks (Table II of 
the original publication II). 
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5.1.2 Plate-screw construct cantilever bending test (I) 
 
The yield bending moment and initial stiffness in both free-form plate groups (Groups 1 and 2) 
were found to be significantly higher than those of the 4-hole plate specimens (Group 3) in the 
plate-screw construct cantilever bending test (Fig. 21-22). Additionally, the yield bending moment 
of the free-form plates secured with countersunk screws (Group 1) was found to be significantly 
higher than that of the free-form plates secured with screws with cut-off screw heads (Group 2, 
Fig. 21). 
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Figure 21. Yield bending moments (mean±SD) in the plate-screw construct cantilever bending test 
(Table III of the original publication I). 
*P<0.05 between Groups 1 and 2, and P<0.0001 between Groups 1 and 3, †P<0.01 between Groups 2 and 3, 
‡95 % CIs do not overlap between Groups 1 and 2 or 3, 95 % CIs do not overlap between Groups 2 and 3 
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Figure 22. Initial stiffness values (mean±SD) in the plate-screw construct cantilever bending test (Table 
III of the original publication I). 
*P<0.01 between Groups 1 and 3, †P<0.05 between Groups 2 and 3, ‡95 % CIs do not overlap between 
Groups 1 and 3, 95 % CIs do not overlap between Groups 2 and 3 
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5.1.3 Plate-screw construct pullout test (II) 
 
No significant differences were found between the groups in any parameters at any time point in 
the plate-screw pullout test (Fig. 23-24). 
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Figure 23. Yield loads (mean±SD) of the free-form plate specimens in the plate-screw construct pullout 
test during incubation under hydrolytic in vitro conditions for 26 weeks (Table III of the original 
publication II). 
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Figure 24. Initial stiffness values (mean±SD) of the free-form plate specimens in the plate-screw 
construct pullout test during incubation under hydrolytic in vitro conditions for 26 weeks (Table III of 
the original publication II). 
 
 
5.2 Effect of the simulated physiological cyclic loading on the fixation 
stability and inherent viscosity of the ankle plate-screw construct under 
hydrolytic in vitro conditions (III) 
 
 
5.2.1 Cyclic biomechanical testing 
 
None of the ankle plate specimens tested failed under cyclic loading during 12 weeks’ incubation 
under hydrolytic in vitro conditions (Table 4). In Group 1, no statistically significant differences 
were found in displacement values in the vertical direction or maximum torque values in the 
rotation direction at the different time points (Fig. 25). No statistically significant differences were 
found in displacement values or in maximum torque values between Groups 1 and 2 at 12 weeks 
(Fig. 26). 
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Figure 25. The axial displacement and torque values (mean±SD) of the Group 1 in the cyclic 
biomechanical test during incubation under hydrolytic in vitro conditions for 12 weeks (III). 
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Figure 26. The axial displacement and torque values (mean±SD) of the Groups 1 and 2 in the cyclic 
biomechanical test after incubation under hydrolytic in vitro conditions for 12 weeks (III). 
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5.2.2 Inherent viscosity 
 
In all study groups, the inherent viscosities of the ankle plate and 2.8 mm screw were significantly 
lower after incubation under hydrolytic in vitro conditions for 12 weeks (and after cyclic loading 
in Groups 1 and 2, Table 4) compared to the initial values (Fig. 27). Group 3 was control group 
without cyclic loading. In addition, no significant differences were found between the groups in 
inherent viscosities at 12 weeks. 
0.0
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Figure 27. The inherent viscosities (mean±SD) of the ankle plate and 2.8 mm screw after incubation 
under hydrolytic in vitro conditions for 12 weeks and after cyclic loading in Groups 1 and 2 (III). 
Group 3 was control group without cyclic loading. Note that SD for all measurements was 0.0 dl/g. 
*P<0.05 between initial and Groups 1, 2 and 3 
 
 
5.3 Effect of hydrolytic in vitro conditions for 104 weeks on the properties of 
the mesh plate and screw (IV) 
 
 
5.3.1 Static mechanical property testing 
 
The mean (±SD) initial maximum shear strength of the mesh plate and 3.1 mm screw was 71±11 
MPa and 41±2 MPa, respectively. During hydrolytic in vitro period for 104 weeks, the mechanical 
strength of the implants behaved as shown in Figure 28.  
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Figure 28. Relative changes (%) in mechanical strength of the mesh plate and 3.1 mm screw during 
incubation under hydrolytic in vitro conditions for 104 weeks (IV). Mesh plate and screw samples had 
lost their mechanical strength after 26 and 52 weeks, respectively, and therefore could not be tested at 
this time point and thereafter. 
 
 
5.3.2 Inherent viscosity and mass loss 
 
The mean initial (±SD) inherent viscosity and mass of the mesh plate were 1.3±0.0 dl/g and 
5.83±0.02 g, respectively. The corresponding values of the 3.1 mm screw were 1.4±0.0 dl/g and 
0.16±0.00 g, respectively. During hydrolytic in vitro period for 104 weeks, the inherent viscosity 
and mass of the implants behaved as shown in Figure 29. 
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Figure 29. Relative changes (%) in inherent viscosity and mass of the mesh plate and 3.1 mm screw 
during incubation under hydrolytic in vitro conditions for 104 weeks (IV). 
 
 
5.4 The clinical suitability of the mesh plate and screws for reconstruction of 
uncontained acetabular bone defects (IV) 
 
The main results of the clinical pilot study are summarized in Table 7. A total of seven patients 
signed informed consent to participate in the study. However, one patient died two months after 
the operation due to reasons unrelated to the operation, leaving six patients to be followed up. A 
successful primary clinical radiological outcome was achieved in all patients. No resorbtion of the 
bone graft or any complications that could be linked to the use of the implants under investigation 
were observed during the follow-up in four patients. In addition, no protrusion of the impacted 
graft was observed beyond the mesh plate. 
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6 DISCUSSION 
 
In the present thesis, product- and indication-specific static and cyclic biomechanical test methods 
were developed and used to investigate the fixation properties of the biodegradable PLDLA/TMC 
bone fixation plate-screw constructs under hydrolytic in vitro conditions. In addition, the 
suitability of the biodegradable PLDLA/TMC mesh plate and screws for a novel clinical 
application in the hip joint was evaluated in both in vitro experiments and in clinical pilot testing.  
 
 
6.1 In vitro testing 
 
In order to achieve sufficient stability, the first biodegradable plates and screws were designed to 
be thicker and wider than the corresponding metal implants. The thickness of the biodegradable 
plates resulted in complaints about their bulkiness [32, 58, 67-68, 87, 92, 138, 178, 201, 208-209, 
219, 247, 317, 400]. Furthermore excessively bulky plates and the protruding screw heads of the 
first generation biodegradable systems have been reported to increase the risk of postoperative 
tissue reactions [92]. Accordingly, smaller and more low-profile implants and implant constructs 
are nowadays preferred. The novel concept of cutting off the screw heads after screw insertion 
provides a lower profile plate-screw construct than the conventional countersunk screw fixation 
where the inserted screws usually lead to somewhat increased thickness of the plate-screw system. 
Based on the in vitro results obtained by developing and conducting static biomechanical test 
methods in this thesis (I-II), the screw heads of the biodegradable screws used to secure the novel 
free-form plate can be cut-off after screw insertion without compromising the initial or 
postoperative biomechanical fixation properties of the implant construct. This finding justifies 
further clinical testing of this novel fixation concept. 
 
Hardware removal rate after surgical treatment of fractures depends on the type of primary 
procedure and hardware used. For example, a secondary procedure for hardware removal after 
surgical treatment of lateral malleolar fracture with metal implants needs to be carried out in 16 % 
of cases already during the first postoperative year [268]. According to recent studies, the majority 
of fracture patients would opt for biodegradable implant over the metallic counterpart if given the 
choice [247, 356]. Use of biodegradable implants instead of metallic hardware has also been 
shown to reduce healthcare costs [50, 52, 56, 159]. Accordingly, the concept of treating fractures 
of the lateral malleolus with biodegradable bone fixation implants can be considered to be 
justified. The biodegradable ankle plate and screws investigated in this thesis (III) have been 
previously shown to provide similar initial fixation of the lateral malleolus as the previously 
clinically proven metallic fixation methods [181, 326]. However, since the strength of 
biodegradable implants reduces as the degradation progresses, it has been unclear whether the 
initial fixation stability provided by the biodegradable ankle plate-screw construct is retained long 
enough postoperatively to allow fracture healing [181]. Therefore, in this thesis, a novel 
indication-specific cyclic biomechanical testing method simulating postoperative physiological 
cyclic loading and degradation of the ankle plate fixation was developed and used. According to 
the biomechanical results of this thesis, the biodegradable ankle plate secured with biodegradable 
screws can be expected to be strong enough for long enough to allow the healing of fractures of 
the lateral malleolus. Together with the recently reported clinical findings [163, 191], the results of 
this thesis indicate that this particular biodegradable PLDLA/TMC ankle plate system could be a 
viable alternative to conventional metallic implants in the treatment of ankle fractures. Currently, 
the ankle plate system investigated is the only commercially available biodegradable plating 
system approved to be used in the treatment of ankle fractures.  
 
It has been suggested that cyclic loading may accelerate hydrolytic degradation of biodegradable 
implants [369]. Furthermore, the lack of cyclic loading during hydrolytic in vitro testing has been 
proposed as a possible reason to account for the observed faster degradation in some studies in 
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preclinical animal models than in hydrolytic in vitro models [65, 227, 236, 303, 321, 369]. 
However, in this thesis (III), the simulated physiological cyclic loading did not have any clinically 
relevant effect on the inherent viscosity (demonstrating hydrolytic in vitro degradation) of the 
tested biodegradable implants. This may be due to the relatively low loads present at the distal 
fibula and applied in the experiments of this thesis. Furthermore, it is naturally also possible that 
the biodegradable material used in these novel implants is less sensitive to loading over time than 
some of the previously tested materials. 
 
In several previous mechanical and biomechanical studies, biodegradable implants and changes in 
their properties have been investigated under hydrolytic in vitro conditions [3, 17, 40, 72, 81, 96, 
100, 181, 227, 232, 236, 240, 250, 256-257, 278-280, 331, 339, 342, 360-361, 367, 369, 372-373], 
as also guidelined in the existing material test standards for biodegradable polymer materials [140-
141]. Accordingly, also all mechanical and biomechanical tests of this thesis were carried out 
under hydrolytic in vitro conditions. All of the implants and implant constructs investigated 
retained most of their initial properties for eight weeks or longer. All free-form plate constructs 
had lost their fixation strength completely within 26 weeks (II) as had the mesh plate (IV). The 
screw used to secure the mesh plate retained its strength up to 52 weeks. In addition, the ankle 
plate fixation withstood simulated physiological loading and hydrolytic in vitro conditions over a 
period of 12 weeks (III). In conclusion, the observed strength retention times and inherent 
viscosity values (III-IV) conform well with the typical time required for bone healing (i.e., 6-12 
weeks) and the return to full weight bearing [4, 6, 20-21, 28, 39, 43, 92, 127, 134, 151, 153, 157, 
159, 163, 190-191, 197-198, 231, 275, 288, 323-324, 347, 380, 382]. Since implant constructs 
appear to lose their fixation stability within 26 weeks, the use of this type of biodegradable 
implants is unlikely to restrict bone growth in pediatric patients [5, 94-95, 138, 199, 223, 405]. 
Less than 15 % of the initial mass of the biodegradable mesh plate and screw remained after two 
years’ incubation under hydrolytic in vitro conditions (IV), and no degradation peaks or any other 
signs of uncontrolled or abrupt degradation were observed.  
 
 
6.2 Clinical testing 
 
Uncontained acetabular defects have traditionally been converted into contained defects by using 
either metallic meshes or bulk bone grafts [327, 395]. Previously, the use of a biodegradable mesh 
plate and screws for this application has not been described in the literature. However, Epstein and 
Hollingsworth (2003), and Wang et al. (2002) have reported good clinical outcomes after using 
PLDLA based biodegradable mesh plates and screws in iliac crest reconstructions after harvesting 
of autograft bone [101, 384]. Encouraged by their results and the in vitro results of this thesis (IV), 
the biodegradable PLDLA/TMC mesh plates and screws were used for the very first time for graft 
containment in acetabular bone defect grafting in carefully selected arthoplasty patients (IV). 
According to the results of the present clinical pilot study, these biodegradable mesh plate and 
screws can be used for converting an uncontained acetabular bone defect into a contained defect to 
allow bone impaction grafting in selected osteoarthritic arthroplasty patients without the need for 
permanent graft containment hardware. Although local fluid accumulation, sterile abscess building 
and even local osteolysis have been observed in some of the earlier clinical studies investigating 
the use of biodegradable bone fixation implants [9, 53, 58], in this clinical pilot study with a 
minimum follow-up time of 19 months, no such complications were observed. Based on these 
findings and in view of the well-known disadvantages of permanent metallic hardware, further 
clinical use and research of these biodegradable implants appear to be fully justified. 
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6.3 Limitations and challenges 
 
In most of the previous biomechanical studies, biodegradable bone fixation implants have been 
evaluated only initially without the presence of hydrolytic in vitro conditions [1, 7, 22, 45-46, 63, 
71, 80, 84, 100, 102, 106, 120, 125, 128, 173, 188, 214-215, 218, 226, 287, 290, 295, 301-302, 
307-308, 310, 320, 326, 346, 349-350, 352, 387, 390, 399, 408], testing has been conducted under 
dry conditions at RT [1, 7, 22, 63, 71, 80, 84, 100, 102, 106, 120, 125, 128, 173, 181, 214-215, 
218, 226, 287, 290, 295, 301-302, 307, 310, 320, 326, 349-350, 352, 387, 390, 399, 408] and when 
hydrolytic in vitro conditions have been included as a part of the protocol, usually it has been 
mechanical rather than biomechanical properties  that has been tested [17, 72, 81, 227, 236, 240, 
250, 256-257, 278-279, 331, 339, 342, 360-361, 367, 372-373]. In addition, the lack of cyclic 
loading has been a criticism laid at the previous biomechanical studies with biodegradable 
implants [40, 80, 280, 303].  
 
In the present thesis (I-III), the biomechanical testing of the biodegradable bone fixation implant 
constructs was conducted under hydrolytic in vitro conditions and all tests were conducted in 
water or ionized water at body temperature. Before this thesis (III), the following three clinically 
relevant factors had not been combined and tested simultaneously in any published biomechanical 
study: 1. complete biodegradable implant constructs evaluated in a simulated bone fragment 
fixation model; 2. simulated postoperative physiological cyclic loading; and 3. hydrolytic in vitro 
degradation implemented over the time period typically required for bone to heal. This kind of 
product- and indication-specific testing protocol for biodegradable bone fixation implants has 
previously only been proposed [80]. 
 
Considering the product- and indication-specific biomechanical test methods, it can sometimes be 
very difficult to determine the loading that the bone fixation implants or implant constructs will 
experience in human patients [1, 40, 80, 106, 120, 125, 135, 181, 250, 281, 293, 302, 305, 307, 
326, 331, 346]. This is why clinical suitability of new fixation implants is often studied by 
comparing the properties of the new devices to those of previously approved and clinically used. 
Metallic implants are obviously generally stronger than the corresponding biodegradable implants 
but often also stronger than that actually necessary for optimal healing. Therefore, even if a 
biodegradable implant is found to provide weaker fixation than a corresponding metal device, 
whether the biodegradable fixation provides sufficient fixation stability or not remains unclear 
unless the actual physiological loads and movements are fully understood and taken into 
consideration. In addition, the postoperative activity level of the patient needs to be taken into 
account when cyclic biomechanical testing protocols are being developed and when the in vitro 
test results have to be evaluated. The number of steps taken daily by healthy people has been 
reported to vary from 200 to 30000 [118]. The estimation of postoperative patient activity is not 
straightforward but at least it can generally be assumed that patients are less active than healthy 
people, especially when they have a plaster cast [331, 346]. In several previous cyclic 
biomechanical studies [1, 63, 80, 181, 226, 290, 320, 326], the total number of loading cycles has 
been very small (5-1000) and thus their clinical relevance can be criticized. Only in two previous 
biomechanical studies [100, 346] has the number of loading cycles been clinically relevant. In the 
studies of Thordarson et al. (1997) and Eppley et al. (1999), the number of cycles was 57700 and 
340000 (on average), respectively [100, 346]. Smutz et al. (1991) in turn used the estimation of 
630 cycles/steps per day as the activity level in their cyclic mechanical study with hydrolytic in 
vitro conditions [331]. This is similar to the estimation used in the present cyclic test (III), i.e., an 
average of 429 cycles/steps per day. However, in this thesis, the number of cycles/steps (and also 
frequency/speed) was increased gradually (in Group 1) as would be expected to happen in real life 
as the healing progressed. In addition, the cyclic loading was conducted during (Group 1) or after 
(Group 2) a 12 week hydrolytic in vitro period but in the studies by Thordarson et al. and Eppley 
et al. only initially. 
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A potential limitation of the cyclic biomechanical test of this thesis (III) is the fact that cyclic 
loading which was intended to simulate physiological loading during postoperative healing period 
could not be carried out daily (as would occur in real life) but was for reason of simplicity applied 
in four phases (corresponding to the progressively increasing postoperative weight bearing) 
including the total amount of loading estimated to occur between the chosen time points (Group 
1). However, it is unlikely that the results of the cyclic testing of this study would have been 
different even had the cyclic loading been carried out on a daily basis, especially when one 
considers that after 12 weeks, no difference was found in the effect of cyclic loading applied either 
in four phases (Group 1) or all at once (Group 2). Phased cyclic loading during the hydrolytic in 
vitro period has also been used in some cyclic mechanical studies [81, 331]. Another obvious 
limitation of this and other in vitro studies is that the positive effect of gradually progressing tissue 
healing on fracture stability cannot be simulated in vitro. 
 
Obviously human cadaver bones would be ideal for biomechanical in vitro testing of 
biodegradable bone fixation implants. Animal cadaver bones may also be used but it should be 
realized that there can be significant differences in the properties of human and animal bones, and 
thus the use of animal bones as substitutes for human bone in in vitro testing has been severely 
criticized [168, 262, 310, 314]. Nonetheless, the use of animal specimens can be considered to be 
permissible due to the limited availability and cost of human cadaver bone [226, 301]. Although 
the use of real bones would have been optimal for biomechanical in vitro testing (and the use of 
PU artificial bone material (II), acrylic tubes (I-II) and PE rods (III) as surrogates of human bone 
can be considered to be another limitation of this thesis), it must be noted that real bones cannot be 
used in a test protocol including long hydrolytic in vitro period. Cadaver bone specimens do not 
tolerate incubation at 37 °C for several weeks without exhibiting changes in their properties i.e., 
tissue decomposition. Therefore, to ensure that the test results obtained reflect the actual fixation 
properties of the tested implants rather than the properties of the carrier material, it is better to use 
a surrogate and carrier material known to tolerate the hydrolytic in vitro conditions and cyclic 
loading without weakening or undergoing other changes in their material properties [1, 10, 11, 13, 
40, 45-46, 96, 100, 116, 143, 280, 301-302]. 
 
The rather small sample size especially in the cyclic biomechanical testing (III) is a general 
limitation of this thesis (and also a limitation of several previous biomechanical studies). However, 
the principal idea of the cyclic testing of this thesis was to test whether the biodegradable ankle 
plating would be capable of withstanding the developed indication-specific loading protocol 
without a failure of fixation during a typical healing period. As none of the fixations failed during 
the cyclic testing, the main conclusion with regard to the ability of the tested devices to withstand 
expected postoperative loading remains valid regardless the sample size. Furthermore, as 
homogenous carrier materials were used instead of human cadaver bone, any bias induced by 
variation in bone quality (a well known limitation of biomechanical testing, a major cause of 
variation in the test results, and the reason why the sample size always need to be higher in a 
cadaveric study than if the same study is conducted utilizing a homogenous carrier material) could 
be excluded [46]. In general, the best way to determine an adequate sample size is by conducting a 
proper statistical power analyses while the study is still being designed. However, the 
determination of sample size requires: 1. realistic understanding of the expected results and 
variation between the individual samples; 2. the desired level of statistical significance for the 
expected results; and 3. the desired statistical power of the study [220]. Since these novel 
biomechanical testing methods were specifically developed for this thesis, there was no previous 
data available on which to base a proper statistical power analysis. 
 
In several mechanical and biomechanical studies where the properties of the biodegradable (and 
also metallic) bone fixation implants or implant constructs have been determined in static tests, the 
maximum rather than yield values have been used as the principal outcome parameter [1, 22, 40, 
45-46, 71-72, 120, 125, 128, 173, 181, 214-215, 218, 226-227, 240, 250, 278, 287, 295, 301, 307-
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308, 342, 349-350, 352, 361, 367, 372-373, 387, 390, 399, 408]. Although maximum values 
provide results that are unambiguous and easy to report and illustrate, their clinical relevance can 
often be seriously questioned, especially when the actual indication-specific physiological loads, 
loading directions and relevant movements are not understood. Furthermore, due to the 
viscoelastic nature of biodegradable materials, maximum loads and strengths are usually reached 
at displacements that would be clinically unacceptable and thus have absolutely no clinical 
relevance [261]. Therefore, the use of yield values can be considered to be more appropriate than 
utilization of maximum values when evaluating clinical suitability of biodegradable bone fixation 
implants and implant constructs. However, maximum values can be used when the aim is to 
demonstrate the retention of the mechanical properties of the degrading implant rather than to 
evaluate the clinical adequacy of its strength. 
 
In several previously published clinical studies with biodegradable bone fixation implants, the 
follow-up time has been shorter than the actual or estimated degradation time of the implants [4-5, 
21, 30, 35, 42, 49, 51, 60, 67-68, 74-75, 86-89, 91, 98, 101, 103-104, 111-112, 114, 123-124, 127, 
148, 151, 157, 164, 171-172, 178, 193-194, 196-198, 207-209, 213, 219, 228, 233, 238-239, 259, 
269, 277, 288, 318, 323, 328, 343, 348, 370, 378, 384, 394, 400, 404, 407] and thus those studies 
only provide a possible indication of the suitability of the initial or short-term (rather than long-
term) strength properties and biocompatibility. As stated previously, the risk of material 
degradation related tissue reactions always exists after implantation of biodegradable implants [9, 
27, 32-33, 43, 51, 53, 58, 67, 75-76, 95, 129, 131, 133-134, 151-152, 156, 160, 163, 169, 191, 200-
201, 207, 213, 219, 223, 227, 245, 257, 273, 276, 282, 285, 289, 305, 316, 323, 336, 357, 360, 
367, 381, 385, 387-388, 404-405] and this seems to be more pronounced when the implants finally 
degrade, rather than immediately after their implantation. Accordingly, in order to confirm 
biocompatibility, the follow-up time in clinical studies should be at least as long as the expected 
time required for complete degradation of the implants. 
 
 
6.4 Considerations for the future 
 
In the future, to provide clinically more relevant information, in vitro testing of biodegradable 
implants should be changed: 1. from testing of individual implants to testing of complete bone 
fixation implant constructs; 2. from determining the initial properties to evaluating the properties 
during degradation; 3. from elucidating the pure mechanical properties to examining the behavior 
under cyclic loading; and 4. from product comparison testing to testing under simulated 
physiological conditions (i.e., more indication-specific testing). As described earlier in this thesis, 
all in vitro testing models, as well as preclinical testing models, always are subject to some 
simplifications and limitations which need to be carefully considered when the clinical suitability 
of biodegradable bone fixation implant constructs are being evaluated. Furthermore, as previously 
proposed also by others [329], detailed standards for testing of materials with clear time-dependent 
properties and behavior, such as biodegradable materials, need to be developed. In addition, there 
should be standards for testing biodegradable implant constructs. 
 
Based on the review of the previously published literature and the findings of this thesis, the 
proposals for a future in vitro testing of new biodegradable bone fixation implants is as follows: 1. 
initial cyclic testing for complete bone fixation implant construct with simulated fracture and 
fracture fixation in human cadaver bones, in simulated body fluids at 37 °C and with a simulated 
physiological and clinically relevant loading protocol taking into consideration the indication-
specific worst case clinical situation; 2. phased cyclic testing for complete fixation implant 
construct under hydrolytic in vitro conditions in simulated body fluid at 37 °C over a clinically 
relevant healing period, with simulated fracture and fracture fixation with a substitute bone 
material known to tolerate hydrolytic in vitro conditions and cyclic loading, and with a simulated 
physiological and clinically relevant loading protocol considering the indication-specific worst 
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case clinical situation; and 3. hydrolytic in vitro series in simulated body fluids at 37 °C over a 
clinically relevant healing period in the context of the expected total degradation time of the 
implant’s material to verify controlled degradation behavior of the implants under investigation. In 
addition, if some detailed design features of the implants need to be compared and investigated, 
also mechanical tests conducted under hydrolytic in vitro conditions in simulated body fluids at 37 
°C over a clinically relevant healing period and taking into the account the worst case clinical 
scenario, can be used in order to obtain a reliable comparison between different designs. All tests 
can be done in comparison to currently clinically used biodegradable or metallic bone fixation 
implant(s) if required. 
 
Due to several disadvantages and complexities in trying to extrapolate the results of preclinical 
studies to predict clinical behavior of the biodegradable fixation implants, preclinical testing is not 
considered to be necessary if the biocompatibility of the implant material is already well-known. 
However, in the case of a novel implant material, preclinical testing should be conducted after in 
vitro testing prior to implantation in humans.  
 
If the results of the in vitro testing and possible preclinical in vivo testing support the safety and 
efficacy of the device, a pilot clinical study should be planned. Preferably the first clinical test 
should be carried out with a protocol in which the health and safety of the patients will not be 
jeopardized under any circumstances by the new method or implants. However, final conclusions 
regarding adequacy of the new device for the intended purpose can only be drawn after conducting 
a proper prospective randomized clinical trial with an appropriate sample size and a long-term 
follow-up. 
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7 SUMMARY AND CONCLUSIONS 
 
In this thesis, product- and indication-specific static and cyclic biomechanical in vitro test methods 
were developed and used in the evaluation of the fixation properties of the biodegradable 
PLDLA/TMC bone fixation plate-screw constructs. According to the results, the biodegradable 
PLDLA/TMC bone fixation implant constructs investigated can be expected to provide sufficient 
fixation stability over a clinically relevant time period and these results justify further clinical 
research with these implants and fixation methods. In addition, after preliminary in vitro testing, 
the biodegradable PLDLA/TMC mesh plate and screws were used clinically for the first time in 
selected osteoarthritic arthroplasty patients to treat uncontained acetabular bone defects in the hip 
joint. These results justify further clinical research to investigate the suitability of the 
biodegradable PLDLA/TMC mesh plate and screws in more demanding applications. 
 
On the basis of the results of this thesis, the following detailed conclusions can be drawn: 
 
1. The screw heads of the biodegradable screws used to secure the novel “free-form” 
osteosynthesis plate can be cut-off after screw insertion without compromising the initial 
or postoperative biomechanical fixation properties of the implant construct. (I-II) 
 
2. The biodegradable ankle plate secured with biodegradable screws can be expected to 
withstand physiological cyclic loading and maintain reduction of a lateral malleolar 
fracture until the fracture has healed. (III) 
 
3. Simulated physiological cyclic loading, applied either during or after a hydrolytic in vitro 
period of 12 weeks, does not have any clinically relevant effect on the inherent viscosity 
(demonstrating hydrolytic in vitro degradation) of the tested biodegradable ankle plate-
screw construct. (III) 
 
4. The biodegradable mesh plate retains most of its mechanical strength for eight weeks and 
gradually loses it thereafter (completely within 26 weeks). The biodegradable screws retain 
their strength longer than the mesh plate. Less than 15 % of the initial inherent viscosity 
and mass of the implants remain after two years under hydrolytic in vitro conditions. (IV) 
 
5. The biodegradable mesh plate and screws can be used for converting an uncontained 
acetabular bone defect into a contained defect to allow bone impaction grafting in selected 
osteoarthritic arthroplasty patients without needing to resort to permanent graft 
containment hardware. (IV) 
7 - Summary and conclusions 
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